+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

List of PDF Full Texts available from EurekaMag Chapter 35690

Chapter 35690 contains a list of PDF Full Texts available from EurekaMag.





Kaneko, M.; Moriyama, M.; Matsumura, H.; Nakamura, H.; Oshiro, S.; Aoki, H.; Shioda, A.; Arakawa, Y., 2003:
SEN virus infection influence the pathological findings in liver, but not affect the incidence of carcinoma

Yeo, A.E.T.; Tanaka, Y.; Umemura, R.P.eiffer T.; Seal, K.H.; Shih, J.W.K.; Alter, H.J.; Edlin, B.R.; O'brien, T.R., 2001:
SEN viruses are common in injection drug users in San Francisco

Banga, S.; Palejwala, V.; Jha, K.; Ozer, H.L., 2000:
SEN6 A 6q27-specific growth suppressor of SV40-immortalized human cells

Singh, R.P.; Agarwal, R., 2002:
SENCAR mouse-skin tumorigenesis model

Ball, S.S.; Mah, V.H., 1999:
SENEX A portable electronic resource for molecular neuropathology and medicine

Dalziel, H.H.; Pohler, E.; Quayle, L.; Cotton, J.P.; Hupp, T.R.; Dillon, J.F., 2004:
SEP53 and AG-2 may act as proto-oncogenes in Barretts metaplasia

Panacek, E.; Albertson, T.; Johnson, D.; Hicklin, G.; Miller, M.; Macarthur, R.; Johnson, S.; Doig, C.; Fischkoff, S.; Barchuk, W.; Teoh, L., 2000:
SEPTEST, a rapid, immunostrip test for serum IL-6 concentrations, prospectively defined a population of patients with sepsis at greater risk for mortality in the MONARCS trial

Lu, M.; Govindjee, R.; Balashov, S.P.; Ebrey, T.G.; Chen, Y.; Menick, D.R.; Crouch, R.K., 2000:
SER193 and THR205 are important components of the proton release pathway in bacteriorhodopsin

Dunwell, Winston, C., 2000:
SERA-IEG-27 Nursery crop and landscape systems; plant evaluation program

Shelly, D.A.; Bodie, B.L.; Sutliff, R.; Paul, R.J., 1999:
SERCA energy metabolism in aorta from wild-type and phospholamban knockout mice

O'neill, S.; Eisner, D.; Hinch, R., 2004:
SERCA inhibition increases Ca efflux activated by waves of Ca release

Ma, T.S.; Bonnette, J.; Nemoto, S.; Defreitas, G.; Carabello, B., 2000:
SERCA overexpression in the mouse produces cardiac hypertrophy and abnormal calcium sequestration

Hasan, F.; Weinberg, E.O.; Lorell, B.H.; Schneider, M.D., 2000:
SERCA-2 expression is decreased in the unloaded heart in vivo

Minamisawa, S.; Sato, Y.; Tatsuguchi, Y.; Fujino, T.; Imamura, S.I.hiro; Fujiwara, M.; Uetsuka, Y.; Matsuoka, R., 2002:
SERCA2 and phospholamban are possible causal genes for hypertrophic cardiomyopathy

Ji, Y.; Babu, J.; Shull, G.E.; Periasamy, M., 1999:
SERCA2 knockout mice develop compensatory mechanisms to maintain Ca2+ homeostasis

Nie, L.; Khan, I.; Misquitta, C.; Grover, A.K.mar, 2003:
SERCA2 mRNA poly A+ tail length in cardiac and stomach smooth muscle

Davia, K.; Bernobich, E.; Hajjar, R.J.; Del Monte, F.; Rosenzweig, A.; Harding, S.E., 1999:
SERCA2a overexpression protects adult cardiomyocytes from calcium overload and enhances viability

Wang, J.F.ng; Yan, X.; Deangelis, J.; Hampton, T.G.; Morgan, J.P., 1999:
SERCA2a protein expression in mouse heart is inhibited by cocaine

Maier, L.S.; Pieske, B.; Horn, W.; Weichert, S.; Franz, W.M., 2000:
SERCA2a-overexpression improves force-frequency and post-rest behaviour due to increased SR Ca-content in isolated myocardium of transgenic rats

Caspersen, C.; Treiman, M., 2000:
SERCA2b, endoplasmic reticulum calcium pump, is a stress-inducible protein

Zhou, Y.; Monahan, S.J.; Lodge, P.A.; Boynton, A.L.; Murphy, G.P.; Salgaller, M.L., 1999:
SEREX identification of human prostate tumor antigens

Dunphy, E.J.; Mcneel, D.G., 2003:
SEREX method to identify immunological responses elicited during immunomodulatory therapy

Jaeger, D.; Jaeger, E.; Bert, F.; Knuth, A., 2000:
SEREX-defined tumor antigens and their clinical application

Sutherland, M.K.ng; Chao, Q.; Desai, S.; Doubleday, M.; Gayo Fung, L.M.; Jalluri, R.; Khammungkhune, S.; Leisten, J.; Lipps, S.G.; Maechler, L., 1999:
SERMS with selectivity for ER-alpha and ER-beta as potential therapies for pathological conditions including osteoporosis and cancer

Sutherland, M.K.ng; Brady, H.; Chao, Q.; Gayo Fung, L.M.; Jalluri, R.; Khammungkhune, S.; Leisten, J.; Lipps, S.G.; Manning, A.M.; Mckie, J.A.; O'leary, E.; Patnaik, N., 2000:
SERMS with selectivity for ER-beta as potential therapies for cancer

Morello, K.C.; Wurz, G.T.; DeGregorio, M.W., 2002:
SERMs: current status and future trends

Miller, C.P., 2002:
SERMs: evolutionary chemistry, revolutionary biology

Draper, M.W., 2002:
SERMs: how do they work?

Chang, J.; Osborne, C.K.nt, 2002:
SERMs and breast cancer prevention

Halbreich, Uriel, 2004:
SERMs and gonadal hormones treatments Theory, reality and factors

Santoro, N.F.; Kovacs, P., 2002:
SERMs effect on the neuroendocrine system and the reproductive organs

Love, Richard, R., 2002:
SERMs effects on cardiovascular risk factors and disease

Shifren, J.L.; Plouffe, L., J., 2002:
SERMs in postmenopausal womens health

Monjan, Andrew, A., 2001:
SERMs, estrogen, and cognitive function Introduction

Viswanathan, K.; Togonu Bickersteth, B.; Vaziri, S.; Marentette, D.; Lucas, A., 2003:
SERP-1, a viral anti-inflammatory serpin alters gene expression profiles in human monocytes and endothelial cells

Grajcar, L.; Ghomi, M.; Huynh Dinh, T.; Baron, M.H., 1999:
SERS reveals adenine properties in RNA and RNA hairpins

Chaudhary, J.; Westphal, S.; Skinner, M.K., 2003 :
SERT A novel Sertoli cell gene product

Tate, C.G.; Baker, C.; Williams, D.C., 2001:
SERT biosynthesis and the problems of overexpression for structural studies

Serretti, A.; Malitas, P.N.; Mandelli, L.; Lorenzi, C.; Alevizos, B.; Nikolaou, C.; Boufidou, F.; Christodoulou, G.N.; Smeraldi, E., 2003:
SERTPR gene variants and lithium efficacy A multicenter Study

Huntington, N.L.lley; Krall, E.A.; Garcia, R.I.; Spiro, A., IIi, 1999:
SES and oral healtah status in an elderly population

Forst, T.; Henniges, W.; Mondok, A.; Lobisch, M.; Larbig, M.; Reifert, S.; Pfutzner, A., 2003:
SET A new device for the measurement of pain perception threshold for detection of peripheral diabetic neuropathy in diabetic patients

Xiao, B.; Wilson, J.R.; Gamblin, S.J., 2003:
SET domains and histone methylation

Alvarez Venegas, R.; Avramova, Z., 2002:
SET-domain proteins of the Su 3-9, E and Trithorax families

Chen, B.; Borinstein, S.C.; Sykes, V.W.; Bogler, O., 2000:
SETA A novel apoptosis related gene in astrocytes

Chen, B.; Bogler, O., 2001:
SETA, an apoptotic modulator in astrocytes by interacting with AIP1 and ALG-2 and rearranging the cytoskeleton

Schultz, D.C.; Ayyanthan, K.; Rauscher, F.J.IIi, 2002:
SETDB1 A new SET domain protein with histone H3, lysine-9-specific methyltransferase activity that contributes to silencing endogenous, euchromatic genes by recruiting HP1

Longazo, T.; Lynch, K.; Leiber, P.; Pedersen, M.; Tuli, M.; Miller, L.; Palmer, S.; Zhang, M., 2002:
SETI and astrobiology Contact An international youth perspective

Chadwick, B.P.; Willard, H.F., 2003:
SETting the stage. Eed-Enx1 leaves an epigenetic signature on the inactive X chromosome

Bao, F.; Azhakanandam, S.; Franks, R.G., 2010:
SEUSS and SEUSS-LIKE transcriptional adaptors regulate floral and embryonic development in Arabidopsis

Alnemri, E.S.; Fernandes Alnemri, T.; Litwack, G., 1999:
SF caspase-1 and compositions for making and methods of using the same

Zuker, C.S.; Adler, J.E.; Ryba, N.; Mueller, K., 2003:
SF, a novel family of taste receptors

Nachtigal, M.W.; Enyeart Vanhouten, D.; Ingraham, H.A., 2000:
SF-1 and DAX-1 A dynamic duo in endocrine development

Davis, A.M.; Seney, M.L.; Parker, K.; Tobet, S.A., 2002:
SF-1 gene expression is important for cell positioning, not cell survival, in the formation of the murine VMH

Strassels, S.A.; Carr, D.B.; Cynn, D.J.; Mcdonagh, M.M.; Rogers, W.H.; E.A., 2003:
SF-36 Scores in Persons at Home 1 Month after Surgery

Ware, J.E., 2000:
SF-36 health survey update

Baltz, R.Y.onne; Bidney, D.L.; Huffman, G.A.; Lu, G.; Scelonge, C.J.; Steinmetz, A.A., 2002:
SF3 promoter and methods of use

Cruz, Julio Cesar, 2003:
SF6 and N2 cardiac oscillations obtained from bolus experiments

Pinkston, J.D.vid; Mangels, M.L., 2003:
SFC/MS in the worlds of pharmaceuticals and low-molecular-weight polymers

Fox, R.V.; Mincher, B.J., 2002:
SFE of plutonium and americium from soil

Bischoff, G.; Riemann, D.; Bischoff, R.; Langner, J.; Hoffmann, S., 2000:
SFM observations of living cells

Lian, J.B.; Trevant, B.; Symons, J.; Komm, B.S.; Bodine, P.V.N.; Stein, G.S., 2002:
SFRP-1, a Wnt antagonist, is expressed during embryonic development in bone and cartilage

Stoehr, R.; Suzuki, H.; Wissmann, C.; Knuechel, R.; Klo Pocki, E.; Dahl, E.; Hofstaedter, F.; Baylin, S.; Hartmann, A., 2003:
SFRP1 expression and promoter hypermethylation analysis in bladder cancer

Knutson, M.D.; Levy, J.E.; Andrews, N.C.; Wessling Resnick, M., 2000:
SFT expression in HFE-knockout mice

Spagnolo, Fred, 2003:
SG pruning machine

Mineta, M.; Ishiguro, H.; Egan, M.; Taubman, J.; Kolachana, B.; Rowe, T.; Lipsky, R.; Uhl, G.R.; Weinberger, D.R.; Goldman, D., 2003:
SGCE, a gene for Myoclonus-dystonia, may also be a risk gene for schizophrenia

Yoo, D.; Kim, B.Y.ung; Campo, C.; Nance, L.; King, A.; Maouyo, D.; Welling, P.A., 2003:
SGK/PKA phosphorylation of Kir11 regulates surface expression

Lin, J.T.; Homerova, D.; Kinne, R.K.H., 1999:
SGLT1 increases Na+-dependent but decreases Na+-independent glucose transport in stably transfected CHO cells

Turner, J.R.; Black, E.D., 2000:
SGLT1-mediated Na+-glucose cotransport activates NHE3 via a p38 MAPK-dependent pathway

Wahl, A.F.; Cerveny, C.H.; Klussman, K.; Chen, J.H.; Francisco, L.V.; Thompson, J.D.; Chace, D.F.; Siegall, C.B.; Francisco, J.A., 2002:
SGN-30, a chimeric antibody to CD30, for the treatment of Hodgkins disease

Francisco, J.A.; Cerveny, C.G.; Meyer, D.L.; Siegall, C.; Senter, P.D.; Wahl, A.F., 2003:
SGN-35, an anti-CD30 antibody-drug conjugate with potent antitumor activity

Hommer, D.; Momenan, R.; Depetrillo, P.; Rawlings, R.; Kaiser, E., 1999:
SGOT on admission predicts brain volume of hospitalized alcoholics

Hirota Nakaoka, N.; Goto, Y., 2000:
SH titration as a tool for understanding the effect of alcohol on proteins

Parkhill, A.L.; Hasbi, A.; Bidlack, J.M., 2001:
SH-SY5Y cells contain mu and delta opioid receptor oligomers and dimers

Hynds, D.L.; Nottingham, S.; Snow, D.M., 2000:
SH-SY5Y neuroblastoma growth cones display different navigation behaviors and signaling on laminin compared to fibronectin Effects of chondroitin sulfate proteoglycan

Buikema, H.; Monnink, S.H.J.; Tio, R.A.; D.Z.euw, D.; Van Gilst, W.H., 2000:
SH-containing ACE-inhibitor enhances biological activity of NO in experimental heart failure

Vidal, M.; Gigoux, V.; Garbay, C., 2001:
SH2 and SH3 domains as targets for anti-proliferative agents

Nakayama, Toshinori, 2003:
SH2 domain containing tyrosine phosphatase SHP-1 controls the development of allergic airway inflammation

Shakespeare, W.C., 2001:
SH2 domain inhibition: a problem solved?

Wang, Y.; Baran, C.; Fang, H.; Tridandapani, S.; Marsh, C.B., 2003:
SH2 domain-containing inositol phosphatase-2 associates with and regulates MCSF receptor-mediated signaling

Grucza, R.A.; Bradshaw, J.M.; Fütterer, K.; Waksman, G., 1999:
SH2 domains: from structure to energetics, a dual approach to the study of structure-function relationships

Nishi, M.; Frantz, J.D.niel; Lee, J.; Werner, E.D.; Shoelson, S.E., 1999:
SH2-B and APS in IGF-1 and growth factor receptor signaling

Sidorenko, S.P.; Mikhalap, S.V.; Shalapatska, L.M.; Berdova, A.G.; Yun, T.; Nichols, K.E.; Clark, E.A., 2000:
SH2-D1a regulates association of CDw150 with SH2-containing inositol phosphatase or protein tyrosine phosphatase SHP-2

Neel, Benjamin, G., 2003:
SH2-containing PTPs and their binding proteins in cancer

Krystal, Gerald, 2001:
SH2-containing inositol-phosphatase

Klein, E.; Kis, L.; Nagy, N., 2002:
SH2D1A in Hodgkins disease derived cell lines

Gross, T.; Huang, D.; Davis, J.; Lanyi, A.; Sumegi, J., 2000:
SH2D1A mutations and Epstein-Barr virus infection in determining phenotype and clinical outcome of X-linked lymphoproliferative disease

Pfleiderer, P.J.mes; Singer, H.A., 2003:
SH3 dependent interaction of CaM Kinase II-delta2 and Fyn

Soulard, A.; Spiridonov, V.; Paoluzi, S.; Cesareni, G.; Winsor, B., 2003:
SH3 domain containing proteins in the organization, signalling and motility of the actin cytoskeleton; a proteomic approach

Whisstock, J.C.; Lesk, A.M., 1999:
SH3 domains in prokaryotes

Sudol, M.; Bork, P.; Chen, H., 2000:
SH3 kinase domain associated protein, a signalling domain therein, nucleic acids encoding the protein and the domain, and diagnostic and therapeutic uses thereof

O'brien, T.J.; Wang, Y., 2000:
SH3 protein, gene, chimeric cells, vectors and expression method for producing the novel protein, and uses

Johnson, J.M.; Fullen, J.; Nicot, C.; Franchini, G., 2003:
SH3-binding domains are dispensable for interaction of HTLV-1 p12I with the free chain of MHC I-Hc

Husain, M.; He, J.C.; Sunamoto, M.; Klotman, P.E., 2003:
SH3-binding motif of HIV-1 Nef is required for podocyte proliferation and anchorage-independent growth

O'brien, T.J.; Wang, Y., 2001:
SH3-containing protein, DNA and uses thereof

Bandman, O.; Guegler, K.J.; Lal, P., 1999 :
SH3-containing proteins

Simpson, F.; Mcpherson, P.S.; Kelly, R.K.; Kay, B.K.; Schmid, S.L., 2000:
SH3-domain-containing proteins and missing molecules in endocytosis

Janssen, O.; Sanzenbacher, R.; Kaplan, D.; Kabelitz, D.; Feller, S.M., 2000:
SH3-mediated interactions with the cytoplasmic tail of CD95L

Predescu, S.A.; Predescu, D.N.; Timblin, B.K.; Gao, X.; Malik, A.B., 2003:
SH3A domain of the endocytic protein intersectin regulates caveolae dynamics

Remme, W.; Cline, C.; Solal, A.C.hen; Hobbs, R.; Keukelaar, K.; Lopez Sendon, J.; Macarie, C.; Mcmurray, J.; Rauch, B.; Zannad, F., 2003:
SHAPE A Pan-European general public heart failure awareness and perception survey

Remme, W.; Mcmurray, J.; Rauch, B.; Zannad, F.; Keukelaar, K.; Cohen Solal, A.; Ruzyllo, W.; Lopez Sendon, J., 2003:
SHAPE A pan-European general public survey on awareness and perception of the clinical, social and economic importance of heart failure

Garriga Canut, M.; Wood, I.C.; Roopra, A.; Millar, N.S.; Buckley, N.J., 2000:
SHARP-1, a bHLH protein, regulates expression of the M1 muscarinic acetylcholine receptor gene

Murayama, Y.; Sugihara, K., 1999:
SHBG gene is a key gene of hormone dependent cell growth in MCF-7 breast cancer cells

Custer, L.; Brauninger, R.; Gibson, D., 1999:
SHE cell transformation assay carcinogenicity predictions for 6 compounds in the ILSI program on alternative carcinogenicity models

Knuepfer, E.; Smith, D.F., 2000:
SHERP, a novel protein expressed in infective stages of the protozoan parasite, Leishmania

D.M.llerat, X.J.; Everman, D.B.; Gurrieri, F.; Morgan, C.T.; Sangiorgi, E.; Gaspari, P.; Amiel, J.; Bamshad, M.J.; Lyle, R.; Allanson, J.E.; L.M.rec, B.; Van Bokhoven, H.; Braverman, N.E.; Radhakrishna, U.; Elghouzzi, V.; Antonarakis, S.; Stevenson, R.E.; Munnich, A., 2003:
SHFM3 is associated with a genomic rearrangement in 10q24

Steel, W.H.; Walker, R.A., 2002:
SHG studies of liquid-liquid interfacial widths using molecular rulers

Bushman, W.; Pepicelli, C.; Munoz, A., 2003:
SHH expression by human prostate cancer cells activates stromal gene expression and accelerates tumor growth

Charrier, J.B.; Teillet, M.A.; L.D.uarin, N.M., 2000:
SHH is necessary for cell survival in both the neural tube and paraxial mesoderm in the early avian embryo

Oropeza, V.C.; Ligas, A.A.; Cebra Thomas, J.A., 2000:
SHH signaling is required for feather bud development

Maeda, K.; Nakamura, K.; Coggeshall, K.M.rk, 2004:
SHIP activity regulates the migration of marginal zone B cells

Nguyen, K.T.i; Highfill, S.L.; Desponts, C.; Ghansah, T.; Kerr, W.G., 2003:
SHIP deficient hosts engraft a broad array of MHC class I mismatched marrow

Takeshita, S.; Namba, N.; Zhao, J.J.; Jiang, Y.; Genant, H.K.; Silva, M.J.; Brodt, M.D.; Helgason, C.D.; Humphries, R.K.; Krystal, G.; Teitelbaum, S.L.; Ross, F.P., 2002:
SHIP deficient mice are severely osteoporotic due to accelerated bone resorption by pagetic-like osteoclasts

Rauh, M.; Pereira, C.; Lane, M.; Damen, J.; Murphy, W.; Mui, A.; Krystal, G., 2002:
SHIP deficient murine peritoneal macrophages are impaired in LPS/IFN gamma-induced NO secretion because of a dramatic overproduction of L-arginase

Rauh, M.J.; Damen, J.D.; Mui, A.; Murphy, W.J.; Krystal, G., 2000:
SHIP is a positive regulator of nitric oxide production

Nakamura, K.; Maeda, K.; Coggeshall, K.M.rk, 2003:
SHIP regulates early stage of B cell development

Beutler, B., 2004:
SHIP, TGF-beta, and endotoxin tolerance

Rauh, M.J.; Pereira, C.; Palmer, J.; Damen, J.; Mui, A.L.F.; Krystal, G., 2002:
SHIP-Deficiency Leads to Anti-Inflammatory Macrophage Programming and Endotoxin Tolerance

Kepley, C.L.nn; Mackay, G.; Morel, P.A.; Zhu, D.; Ke, Z.; Saxon, A., 2003:
SHIP-Grb2-Dok complexes prevent Fc RI-mediated human mast cell activation and regulate Fc RII-mediated inhibition

Hashimoto, A.; Hirose, K.; Okada, H.; Kurosaki, T.; IIno, M., 1999:
SHIP-independent pathway for regulation of store-operated Ca2+ influx in B lymphocytes

Kole, H.K.; Chi, A.W.; Bolland, S., 2004:
SHIP1 associates with c-Cbl and modulates T cell receptor function

Daeron, M.; Bruhns, P.; Lesourne, R.; Malbec, O.; Fridman, W.H., 2001:
SHIP1-mediated negative regulation of cell activation and proliferation by FcgammaRIIB

Baumgartener, J.W., 2003:
SHIP2: an emerging target for the treatment of type 2 diabetes mellitus

Wang, Y.; Keogh, R.J.; Tridandapani, S.; Marsh, C.B., 2004:
SHIP2 is Recruited to the Cell Membrane via its Proline-Rich Domain upon M-CSF Stimulation and Regulates M-CSF-Induced Signaling

Cambier, J.C.; Brauweiler, A.; Marschner, S.; Tamir, I., 2001:
SHIPs and their Doks in regulation of lymphocyte function

Agy, M.B.; Thompson, J.; Grant, R.F.; Coon, E.M.; Finn, E.E.; Kennedy, B.J.; Anderson, D.; Morton, W.R., 1999:
SHIV 229, a pathogenic virus derived from SHIV HXBc2 following a single blood passage in Macaca nemestrina

Busch, M.; Lu, D.; Fritts, L.; Lifson, J.; Miller, C.J., 2003:
SHIV 896 DNA provirus as a live-attenuated vaccine

Esser, U.; Reyes, R.; Luciw, P., 2003:
SHIV SF33A but not SF162P infection disrupts neonatal T-cell development and leads to decreased thymic output as determined by trafficking properties

Nakasone, T.; Shinohara, K.; Ami, Y.; Yoshino, N.; Kaizu, M.; Takahashi, E.; Touzjian, N.; Lu, Y.; Nagai, Y.; Honda, M., 2000:
SHIV carrying C1-V3 of HIV-1 subtype E infected to a cynomolgus monkey

Robinson, H.L.; Candido, M.; Montefiori, D.C.; Johnson, R.P.ul; Manson, K.; Wyand, M.S., 1999:
SHIV-IIIB vaccine study using DNA primes and alternative boosts Neutralizing antibody independent protection by a DNA prime and a recombinant fowl box boost

Buch, S.J.; Smith, M.S.; Narayan, O., 1999:
SHIVKU-induced encephalitis in macaques is associated with expression of IL-4 nnd IL-10

Kunos, G.; Jarai, Z.; Wagner, J.A.; Compton, D.R.; Martin, B.R.; Zimmer, A.M.; Bonner, T.I.; Razdan, R.K.; Zimmer, A., 1999:
SHJ+ anandamide induces nitric oxide-independent mesenteric vasodilation via a novel endothelial site of action

Golden, T.A.; Schauer, S.E.; Lang, J.D.; Ray, A.; Castle, L.A.; Meinke, D.W.; Mushegian, A. , 2000:
SHORT INTEGUMENTS1 encodes an unusual RNA-interacting protein with pleiotropic functions throughout Arabidopsis development

Cohen, H.; Jones, H.; Stainsby, D., 2004:
SHOT 6th Annual Report - errors remain the predominant finding

Munns, C.F.J.; Labrom, R.; Flanagan, S.; Rappold, G.; Philips, G.; Vickers, D.; Glass, I.; Batch, J., 2000:
SHOX Effect in Leri-Weill dyschondrosteosis

Munns, C.F.J.; Flanagan, S.; Rappold, G.; Vickers, D.; Hyland, V.; Glass, I.; Batch, J., 2000:
SHOX Growth effect in Leri-Weill dyschondrosteosis

Tiecke, E.; Blaschke, R.; Tickle, C.; Rappold, G., 2003:
SHOX and limb development

Muesebeck, J.; Mohnike, K.; Beye, P.; Toennies, H.; Stumm, M.; Wieacker, P., 2001:
SHOX deletion screening by FISH in patients with short stature

Stuppia, L.; Calabrese, G.; Morizio, E.; Gatta, V.; Pintor, S.; Franchi, P.G.anciali; Fantasia, D.; Palka, G., 2002:
SHOX deletions and point mutations in 56 patients with short stature

Mariani, S.; Falcinelli, C.; Madeo, S.; Ferrari, P.; Forabosco, A.; Bernasconi, S., 2000:
SHOX gene analysis in Leri-Weill dyschondrosteosis

Faravelli, F.; Camera, G.; Pierluigi, M.; Baldi, M.; Dagna, F., 2001:
SHOX gene deletion in a male patient without short stature and Madelung deformity

Falcinelli, C.; Mariani, S.; Madeo, S.; D.S.nctis, C.; Forabosco, A.; Bernasconi, S., 2000:
SHOX gene deletions in Leri-Weill dyschondrosteosis

Bernasconi, S.; Mariani, S.; Falcinelli, C.; Milioli, S.; Iughetti, L.; Forabosco, A., 2001:
SHOX gene in Leri-Weill syndrome and in idiopathic short stature

Iughetti, L.; Milioli, S.; Percesepe, A.; Mariani, S.; D.S.nctis, C.; D.L.ca, F.; Chiumello, G.; Chiarelli, F.; Radetti, G.; Buzi, F.; Tenconi, R.; Pasquino, A.M.; Cisternino, M.; Forabosco, A.; Bernasconi, S., 2002:
SHOX gene mutations in Leri-Weill syndrome

Schwarze, C.P.; Binder, G.; Ranke, M.B., 1999:
SHOX gene mutations in children with idiopathic short stature - screening and therapy with rhGH

Nahum, O.; Yeshaya, J.; Legum, C.; Udler, Y.; Shohat, M., 2003:
SHOX haploinsufficiency causing Leri-Weill syndrome in three Israely families

Rappold, G., 1999:
SHOX mutations cause growth failure in Turner and Leri-Weill syndrome

Ji, L.; Han, H.J.ng; Wei, L.; Wang, S., 2003:
SHP gene is associated with high birth weight in Chinese newborns

Mizuno, K.; Tagawa, Y.; Mitomo, K.; Arimura, Y.; Hatano, N.; Katagiri, T.; Ogimoto, M.; Yakura, H., 2000:
SHP-1 dephosphorylates BLNK/SLP-65 and selectively regulates JNK activation in B cells

Paessler, M.; Kossev, P.; Raghunath, P.; Tsai, D.; Ramaglian, P.; Tomaszewski, J.; Arber, D.; Hsi, E.; Wasik, M.A., 2001:
SHP-1 expression correlates with post-germinal center cell derivation of post-transplant lymphoproliferative disorders

Massa, P.T.; Wu, C.; Ropka, S.L., 1999:
SHP-1 haploinsufficiency increases susceptibility to CNS demyelination

Zhao, J.; Lurie, D.I., 2001:
SHP-1 in the deafferented murine auditory brainstem

Sathish, J.G.; Johnson, K.G.; Fuller, K.J.; Leroy, F.G.; Sims, M.J.; Matthews, R.J.mes, 1999:
SHP-1 is constitutively associated with phosphotyrosine containing ligands in T-lymphocytes

White, E.D.; Andrews, R.P.; Rosa Rosa, L.; Khurana Hershey, G.K., 2000:
SHP-1 is required for IL-4 dependent FCepsilonRI modulation in murine mast cells

Mizuno, K.; Tagawa, Y.; Mitomo, K.; Watanabe, N.; Ogimoto, M.; Yakura, H., 2002:
SHP-1 positively regulates BCR-induced apoptosis by modulating association of BLNK with Nck and activation of JNK

Mizuno, K.; Tagawa, Y.; Mitomo, K.; Katagiri, T.; Ogimoto, M.; Yakura, H., 2001:
SHP-1 positively regulates apoptosis by dephosphorylating BLNK in B cells

Massa, P.T.; Ropka, S.L.; Saha, S.; Fecenko, K.L., 2001:
SHP-1 promotes anti-viral and anti-apoptotic pathways in oligodendrocytes

Massa, P.T.; Ropka, S.L.; Saha, S.; Beuler, K.L.; Fecenko, K., 2001:
SHP-1 protects against IL-6-induced apoptosis in oligodendrocytes

Fuenmayor, J.; Blasini, A.M.; Rodriguez, M.A., 1999:
SHP-1 redistributes to the cytoskeletal compartment and associates with ZAP-70 during activation of human PB T cells

Hardy, I.; Olivier, M., 2002:
SHP-1 regulation of AP-1 functions

Liu, D.; Martino, G.; Thangaraju, M.; Sharma, M.; Halwani, F.; Shen, S.H.iang; Patel, Y.C.; Srikant, C.B., 2000 :
SHP-1-dependent, caspase-8-mediated, acidification and apoptosis are not dependent on mitochondrial dysfunction

Olivier, Martin, 2000:
SHP-1-mediated macrophage signalling subversion during leishmaniasis

Yu, W.M.i; Hawley, T.S.; Hawley, R.G.; Qu, C.K.i, 2002:
SHP-2 Tyrosine Phosphatase Overrides the Role of SHP-1 Phosphatase in Interleukin-3 Signaling, Functioning in Both Catalytic Dependent and Independent Manners

Yusa, S.I.hi; Campbell, K.S., 2003:
SHP-2 can play a direct role in the inhibitory function of killer cell Ig-like receptors in human NK cells

Hatakeyama, Masanori, 2004:
SHP-2 tyrosine phosphatase as a cellular target of the H pylori oncogenic factor CagA

Chen, J.; Yu, W.M.i; Qu, C.K.i, 2003:
SHP-2 tyrosine phosphatase negatively regulates hematopoietic cell survival by dephosphorylation of Stat5

Chernock, R.D.; Ganju, R.K., 2000:
SHP2 and CBL participate in alpha-chemokine receptor CXCR4-mediated signaling pathways

Schaper, F.; Lehmann, U.; Schmitz, J.; Weissenbach, M.; Hoertner, M.; Friederichs, K.; Behrmann, I.; Tsiaris, W.; Sasaki, A.; Schneider Mergener, J.; Yoshimura, A.; Neel, B.G.; Heinrich, P.C., 2002:
SHP2 and SOCS3 contribute to Y759-dependent attenuation of IL-6-signaling through gp130

Tanowitz, M.; Si, J.; Feng, G.S.; Mei, L., 1999:
SHP2 negatively regulates neuregulin-signaling

Lehmann, U.; Sobota, R.M.; Heinrich, P.C.; Schaper, F., 2003:
SHP2 specifically inhibits IL-6 signal transduction Specificity of SHP2 for attenuating IL-6 signal transduction

Davis, A.; Muir, P.; Allardice, J.A.ne; Clark, K.; Groves, J.; Molenaar, M.; Robson, G., 2002:
SHPA guidelines for self-administration of medication in hospitals and residential care facilities

Society, O.Hospital Pharmacists, O.Australia Committee, O.Specialty Practice, I.Oncology, 1999:
SHPA standards of practice for the safe handling of cytotoxic drugs in pharmacy departments

Society, O.Hospital Pharmacists, O.Australia Committee, O.Specialty Practice, I.Oncology, 2000:
SHPA standards of practice for the transportation of cytotoxic drugs from pharmacy departments

Fukunaga, A.; Nagai, H.; Xijun, Y.; Noguchi, T.; Matozaki, T.; Nishigori, C.; Horikawa, T., 2003:
SHPS-1/SIRP alpha regulates migration of Langerhans cells from epidermis to draining lymphnode

Pedrosa, R.; Soares, D.S.lva, P., 2003:
SHR renal proximal tubules respond to dopamine D3 receptor stimulation with inhibition of the Na+/H+ exchanger

Nangaku, M.; Miyata, T.; Ishikawa, N.; Inagi, R.; Ueda, Y.; D.S.rihou, C.V.n Ypersele; Kurokawa, K., 2003:
SHR/NDmc-cp rat is a model of hypertensive type 2 diabetes with massive proteinuria and progressive glomerular sclerosis and with an increase in advanced glycation end product genesis

Murphy, B.; Numes, C.; Fairhurst, A.M.; Donnelly, M.; Mellin, T.N.; Strack, A.M., 1999:
SHU9119 inhibits MTII, but not dexfenfluramine induced anorexia

Bello, H.; Dominguez, M.; Dashti, A.A.; Gonzalez Rocha, G.; Amyes, S.G.B., 2002:
SHV-39 A new extended-spectrum beta-lactamase found throughout Chile

Giffard, P.M.; Howard, C.H.; Schooneveldt, J.; Nimmo, G.; Van Daal, A.; Kelly, G., 2001:
SHV-extended spectrum beta-lactamase diagnosis by mini-sequencing

Tzouvelekis, L.S.; Bonomo, R.A., 1999:
SHV-type beta-lactamases

Gaestel, M., 2002:
sHsp-phosphorylation: enzymes, signaling pathways and functional implications

Ionescu, O.; Sonnet, E.; Roudaut, N.; Bercovici, J.P.; Kerlan, V., 2003:
SIADH and diabetes insipidus An endocrine complication of pituitary adenoma surgery

Kao, C-D.; Chen, J-T.; Wu, Z-A.; Shan, D-E.; Liao, K-K., 2003:
SIADH and seizure associated with immunoglobulin therapy

Collins, A.; Anderson, J., 2000:
SIADH induced by two atypical antipsychotics

Kumar, P.D.leep; Nartsupha, C.; Koletsky, R.J., 2000:
SIADH occurring in encephalomalacia resulted from head injury in a patient with polysubstance abuse

Bruzzoni Giovanelli, H.; Faille, A.; Linares Cruz, G.; Nemani, M.; Germani, A.; Millot, G.; Calvo, F., 2000:
SIAH-1 transfection induces p21waf-1 activation and alteration of the mitotic program in MCF-7 cells

Santos, C.M.randa; Alvarenga, R.M.P.pais; Poser, C.M., 2001:
SIAPEM, a Brazilian and South American database for multiple sclerosis evaluation

Brodkin, J.; Sternfeld, S.; Mccunney, S.; Lloyd, G.K.nneth; Menzaghi, F., 1999:
SIB-1508Y, a neuronal nicotinic agonist, reverses learned helplessness in rats

Bontempi, B.; Whelan, K.T.; Risbrough, V.B.; Rao, T.S.; Buccafusco, J.J.; Lloyd, G.K.nneth; Menzaghi, F., 2001:
SIB-1553A, -4- ethylthiophenol hydrochloride, a subtype-selective ligand for nicotinic acetylcholine receptors with putative cognitive-enhancing properties Effects on working and reference memory performances in aged rodents and nonhuman primates

Crimaldi, A.J.; Wu, Y.; Abayomi, O.; Morris, M.; Lauve, A.; Zhou, J.; Wu, Q.; Schmidt Ullrich, R., 2003:
SIB-II Improved parotid gland sparing using a two-phase planning strategy for head and neck intensity modulated radiotherapy

Italian Society, O.Clinical Biochemistry And Clinical Molecular Biology, 2000:
SIBioC 2000 32nd National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology, Rimini, Italy, September 12-15, 2000

Italian Society, O.Clinical Biochemistry And Clinical Molecular Biology, 2003:
SIBioC 2003 35th National Congress of the Italian Society of Clinical Biochemistry and Clinical Molecular Biology, Florence, Italy, October 14-17, 2003

Mitchell, E.A., 2000:
SIDS Facts and controversies We need to promote the established risk-reducing behaviours, which are based on strong scientific evidence

Sawaguchi, T.; Nishida, H., 2001:
SIDS doesn't exist

Weinberger, B.; Ostfeld, B.M.; Shen Schwarz, S.; Hegyi, T., 2001:
SIDS is associated with markers of placental inflammation

Smith, D.; Davies, S.; Spanel, P., 2000:
SIFT-MS analysis of breath isoprene A marker of treatment stress in haemodialysis patients?

Wald, D.; Qin, J.; Zhao, Z.; Naramura, M.; Tian, L.; Towne, J.; Sims, J.E.; Stark, G.R.; Li, X., 2003:
SIGIRR, a negative regulator of IL-1R-, TLR4-and TLR9-mediated signaling

Wald, D.; Didonato, J.; Mizel, S.; Stark, G.R.; Li, X., 2002:
SIGIRR, a novel of the Toll/IL-1R superfamily

Howard, G.C.W., 2003:
SIGN guidelines for testicular cancer

Guseva, O.A.; Grigorian, S.S., 1999:
SIL-2R as criteria of immunocorrecting therapy efficacy in kidneiallotransplantat recipients

Oliveira, J.G.G.; Xavier, P.; Sampaio, S.; Mendes, A.A.; Guerra, L.E.R., 2000:
SIL-6R and CD44H in early days post-kidney transplantation

Moleti, M.L.isa; Testi, A.M.ria; Cimino, G.; Elia, L.; D.P.opris, S.; Tafuri, A.; Mancini, M.; Giona, F.; Foa, R.; Mandelli, F., 2002:
SIL/TAL1 Deletion in Childhood T-Cell Acute Lymphoblastic Leukemia Identifies a Subgroup of Patients with Aggressive Presentation and a Poor Outcome

Skrivanek, Z.; Irwin, M.; Lin, S.; Wright, F.A., 1999:
SIMPLE A linkage program that incorporates interference

Erassov, A.; Emili, A., 2003:
SIMS A new database search algorithm for identifying protein post-translational modifications and sequence substitutions from peptide MS/MS spectra

Chen, F.; Jiang, M.; Sun, W.; Birnbaumer, L.; Wetzel, G.T., 2002:
SIN-1, a nitric oxide synthase donor, reduces isoproterenol-stimulated calcium current in both wild type and genetically engineered mouse hearts Findings from G protein subunit gene knockout mice

Han, S-Hyun.; Shin, K-Yun.; Lee, S-Soo.; Ko, M-Suck.; Jeong, D.Kee.; Oh, H-Shik.; Yang, B-Chul.; Cho, I-Cheol., 2010:
SINE indel polymorphism of AGL gene and association with growth and carcass traits in Landrace x Jeju Black pig F(2) population

Weiner, A.M., 2002:
SINEs and LINEs: the art of biting the hand that feeds you

Matsuzawa, S.I.hi; Reed, J.C., 2000:
SIP A protein that bridges SIAH-family E3 ubiquitin ligases to the SCF complex component SKP1

Maruhashi, M.; Van, D.P.tte, T.; Nelles, L.; Verschueren, K.; Huylebroeck, D.; Kondoh, H.; Higashi, Y., 2001:
SIP1 is essential for notochord, somite and neural tube formation during mouse development

Collart, C.; Remacle, J.E.; Van Grunsven, L.A.; Verschueren, K.; Huylebroeck, D., 2000:
SIP2, an RNA-binding Smad-interacting protein, may identify a new mechanism of Smad function in TGF-beta signal transduction

Taborski, U.; Basser, S.; Behm, T.; Karges, H.; Kiessig, S.T.; Rethwilm, M.; Richter, S.; Storch, H.; Wolter, K.; Hellstern, P., 2000:
SIPLA - Safety of donor under intensified plasmapheresis

Sauve, A.A.; Schramm, V.L., 2004:
SIR2: the biochemical mechanism of NAD(+)-dependent protein deacetylation and ADP-ribosyl enzyme intermediates

Guarente, Leonard, 2001:
SIR2 genes regulate aging in yeast and C elegans

Brandileone, M.C.; Casagrande, S.T.; Zanella, R.C.; Guerra, M.L.; Vieira, V.S.; Bokerman, S.; Berezin, E.N.; Melles, C.E.; Pignatari, A.C.; Santos, A.R.; Tomasz, A.; Austrian, R.; Difabio, J.L., 1999:
SIREVA Surveillance of invasive Streptococcus pneumoniae in Brazil Molecular characterization of penicillin-resistant strains

Wertheimer, E.; Takeda, J.; Tennenbaum, T.; Kahn, C.R.; Sizyakov, G., 2002:
SIRKO The skin specific insulin receptor knockout mouse

Newman, C.; Russell, G.; Shore, W.; Gock, D.; Ryan, R., 2001:
SIROCIRC recirculatory phosphine fumigation systems at the Xizui grain terminal, Dalian, China

Ullrich, A.; Kharitonenkov, A.; Chen, Z., 2003:
SIRP proteins and uses thereof

Sulkowski, J.; S.H.llaire, C.; Turchan, J.; Nath, A.; Van Den Berg, T.; Conant, K., 2003:
SIRP signaling modulates neuronal Akt

Narayanan, V.; Mi, Z.P.; Lagenaur, C.F., 2003:
SIRPa-associated molecules in the brain

Czock, D.; Keller, F., 2002:
SIRS and sepsis Acute renal failure Renal replacement therapy and drug dose adjustment

Leszczyszyn, J.; Gerber Leszczyszyn, H.; Jelen, M.; Lebski, I.; Skoczylas, M., 2002:
SIS biomaterial application in treatment of fecal incontinence caused by anal sphincter injury An animal study

Valenti, M.P.ola; Namer, I.J.; Carcangiu, R.; Massa, R.; Thiriaux, A.; Marescaux, C.; Kehrli, P.; Hirsch, E., 2000:
SISCOM participate to differentiate simple from complex forms of dysembryoplastic neuroepithelial tumors ?

Melo, N.; Ribeiro, M.; Lobao, Y.; Rezende, K.; Silva, L.; Malerbi, D., 2003:
SISPED A software to monitor foot complications and prevent foot amputation in diabetic patients

Milavec-Puretic, V.; Lipozencić, J.; Di Biagio, N.; Lakos-Jukic, I., 2001:
SIT in Croatia

Songsanand, P.; Cockerham, K.P.; Eiseman, A.S.; Rosamont Morgan, E., 1999:
SITA An expedient technique to quantitate the visual impact of dermatochalasis and ptosis

Capris, P.; Corallo, G.; Gatti, G.; Zingirian, M., 1999:
SITA and full threshold strategies in the study of the perimetric defects in glaucoma

Stickney, T.L.; Brito, C.F.; Withrow, K.R.; Wall, M., 1999:
SITA standard compared with full threshold testing in patients with hemianopia

Wingfield, C.; Booth, J.; Sheridan, P.; Detmer, J.; Turczyn, J., 2003:
SIV 40, performance characteristics of an exceptionally sensitive, quantitative assay for SIV RNA using branched DNA technology

Puffer, B.A.; Pohlmann, S.; Edinger, A.L.; Sanchez, M.D.; Reitter, J.; Watry, D.D.; Fox, H.S.; Desrosiers, R.C.; Doms, R.W., 2002:
SIV CD4-independence is associated with macrophage tropism, neutralization sensitivity, and attenuated pathogenicity

Rowles, J.L.; Cole, K.S.efano; Sturgeon, T.; Jin, J.; Murphey Corb, M.; Montelaro, R.C., 2003:
SIV ENV GP140 domain-specific antibody responses in rhesus macaques inoculated with attenuated SIV/17E A novel strategy to understanding delayed humoral maturation

Reinhart, T.A.; Bell, I.; Ashman, C.; Maughan, J.; Hooker, E.; Cook, F.; Schaefer, T., 1999:
SIV Nef binds to the T cell receptor zeta chain and down-modulates the TCR/CD3 complex

Glenn, A.A.; Novembre, F.J., 2002:
SIV cloned from the brain of an SIVsmmFGb-infected pig-tailed macaque shows unique tropism and Env expression

Lum, R.; Martin, K.L.; Kodama, T., 1999:
SIV coreceptor activity of CXCR3 expressed on T cells and ECRF3 encoded by HVS

Sawai, E.; Low, T.; Hamza, S.; Stout, M.; Ye, M.; Weber, J.; Schmidt, K.; Shaw, K.; Luciw, P., 1999 :
SIV delta Nef and SIV-IL2 are pathogenic in rhesus macaques

Orandle, M.; Alvarez, X.; Williams, K.; Lackner, A., 2000:
SIV encephalitis in rhesus macaques is associated with overexpression of interferon-gamma and tumor necrosis factor-alpha

Zaragoza, M.; Dailey, P.; Dandekar, S., 2001:
SIV genetic diversity and viral load analysis of gut-associated lymphoid tissue compared to other lymphoid and non-lymphoid organs in primary SIV infection

Maclean, A.G.; Shvetz, D.E.; Schwartz, A.J.; Alvarez, X.; Tham, I.C.; Williams, K.C.; Lackner, A.A., 2000:
SIV infection primes peripheral blood mononuclear cells for chemotaxis to CC chemokines

Baskin, G.B.; Habis, A.; Murphey Corb, M.; Levy, L.S., 1999:
SIV-associated lymphoma in rhesus monkeys A model for AIDS-associated lymphoma

Burudi, E.M.E.; Marcondes, M.C.G.; Huitron Resendez, S.; Sanchez, M.; Henriksen, S.J.; Fox, H.S., 2001:
SIV-induced CNS dysfunction Poisoning the neurons

Marcondes, M.C.G.; Burudi, E.M.E.; Huitron Resendez, S.; Sanchez, M.; Henriksen, S.J.; Fox, H.S., 2001:
SIV-induced abnormality in CNS evoked potentials correlates with activated CD8+ T cells in the brain

Westmoreland, S.; Cheng, L.; Williams, K.; Debakker, C.; Wilson, M.; Gonzalez, G.; Lackner, A., 2000:
SIV-induced neuronal injury in rhesus neonates

Maggiorella, M.T.resa; Koanga Mogtomo, M.L.; Sernicola, L.; Corrias, F.; Negri, D.R.M.; Cesolini, A.; Baroni, C.D.; Verani, P.; Titti, F., 1999:
SIV-infected non-human primates as an animal model to study the pathogenesis of lymphoproliferative disorders

Cromwell, M.; Alvarez, X.; Altman, J.D.; Luster, A.; Lackner, A.A.; Johnson, R.P.ul, 2002:
SIV-specific CD8+ T cells traffic to the female genital mucosa and express receptors for inflammatory chemokines

Nilsson, C.; Makitalo, B.; Karlen, K.; Fredlund, H.; Berglund, P.; Liljestrom, P.; Sutter, G.; Erfle, V.; Biberfeld, G.; Thorstensson, R., 2001:
SIV-specific immune responses elicited by a prime-boost regimen based on semliki forest virus and modified vaccinia ankara

Schafer, F.; Schneider, T.; Bernardi, C.; Kewenig, S.; Stahl Hennig, C.; Stolte, N.; Stallmach, A.; Kaup, F.J.; Zeitz, M., 1999:
SIV-specific mucosal immunoglobulin production contributes to long-term survival in SIV infected rhesus macaques

Luciw, P.A.; Sawai, E.T.; Reyes, R.; Schmidt, K.A.; Mandell, C.P., 1999:
SIV/HIV-1 nef recombinant virus infection of macaques and simian AIDS

Petit, P.X.; Py, B.; Mrugala, D.; Biard Piechaczyk, M.; Benichou, S., 2004:
SIVA A new intracellular ligand of the CD4 receptor modulating T lymphocyte apoptosis via a caspase-dependent mitochondrial pathway

Jones, L.A.; Ahmad, S.; Chan, K.S.; Yilma, T., 2003:
SIVDELTAnef expressing IFN-gamma is attenuated for neonate macaques

Perković, M.; Norley, S.; Sanzenbacher, R.; Battenberg, M.; Panitz, S.; Coulibaly, C.; Flory, E.; Siegismund, C.; Münk, C.; Cichutek, K., 2010:
SIVagm containing the SHIV89.6P Envelope gene replicates poorly and is non-pathogenic

Diop, O.M.; Gueye, A.; Dias Tavares, M.; Kornfeld, C.; Faye, A.; Ave, P.; Huerre, M.; Corbet, S.; Barre Sinoussi, F.; Muller Trutwin, M.C., 2001:
SIVagm primary infection in its natural host High level of viral replication without induction of follicular hyperplasia

Villinger, F.; Bostik, V.; Mayne, A.E.; Bostik, P.; Adams, D.; Kim, C.N.; Otten, R.A.; Heneine, W.; Switzer, W.M.; Novembre, F.; Mcclure, H.M.; Folks, T.M.; Ansari, A.A., 2003:
SIVhu is apathogenic for newborn rhesus macaques but protection against heterologous SHIV896p challenge requires detectable perinatal replication of SIVhu

Pohlmann, S.; Lee, B.; Meister, S.; Krumbiegel, M.; Leslie, G.; Doms, R.W.; Kirchhoff, F., 2001:
SIVmac utilizes human and sooty mangabey but not rhesus macaque STRL33 for efficient entry

Lauret, E.; Matheux, F.; Rousseau, V.; Larghero, J.; Boson, B.; D.M.eyer, E.; Legrand, R.; Dormont, D., 1999:
SIVmac251 resistance of macaques infused with IFN-beta-engineered lymphocytes

Smith, M.S.; Buch, S.; Niu, Y.; Berry, T.; Li, Z.; Adany, I.; Novembre, F.; Narayan, O., 2002:
SIVsmmPGm infection of lymphoid and brain tissue of M nemestrina

Miura, K.; Lee, J.; Miura, T.; Hasegawa, P.M., 2010:
SIZ1 controls cell growth and plant development in Arabidopsis through salicylic acid

Alonso, D.O.; Daggett, V., 2001:
Simulations and computational analyses of prion protein conformations

Hartley, J.A.; Brooks, N.; Mchugh, P.J.; Clingen, P.H.; Gregson, S.J.; Howard, P.W.; Thurston, D.E., 2000:
SJG-136 A novel DNA sequence specific minor groove crosslinking agent with significant antitumor activity

Simmons, W.J.; Koneru, M.; Ponzio, N.M., 2002:
SJL lymphoma specific Th1 cells facilitate the development of tumor-specific cytotoxic effector cells

Braga, J.; Thackeray, F.; Treil, J.; Borianne, P., 2001:
SK 859, an infant early hominid preserving endocranial features Evidence from osteodental maturation studied using computed tomography

Tsukamoto, Katsura, 2001:
SK-896 Prokinetic, motilin agonist

Sailer, C.A.; Kaufmann, W.A.; Trieb, M.; Knaus, H.G., 2001:
SK2 channels in the rodent brain Regional distribution and co-localization with marker antibodies

Taylor, M.S.ephen; Bonev, A.D.; Gross, T.P.; Brayden, J.E.; Bond, C.T.; Adelman, J.P.; Nelson, M.T., 2003:
SK3 channels modulate resistance artery function through an endothelium-derived hyperpolarizing influence

Herrera, G.M.; Pozo, M.J.; Zvara, P.; Adelman, J.P.; Nelson, M.T., 2002:
SK3 channels regulate urinary bladder smooth muscle function in vivo

Schraven, B.; Marie Cardine, A.; Meuer, S.; Kirchgessner, H., 1999:
SKAP55 compositions and methods of use therefor

Fanger, C.M.; Rauer, H.; Neben, A.L.; Rosa, J.C.; Ganellin, C.R.; Chandy, K.G.; Cahalan, M.D., 2000:
SKCa channel blockers reduce the amplitude and alter the kinetics of Jurkat T cell Ca2+ responses

Ikeda, H.; Adachi, K.; Hasegawa, M.; Sato, M.; Nakamura, S.; Hirose, N.; Koshikawa, N.; Waddington, J.L., 1999:
SKF 83959, an anomalous antagonist of dopamine-sensitive adenylyl cyclase, exhibits a dopamine D1-like receptor agonist profile in the regulation of jaw movements by D1-like D2-like receptor synergism

Ijuin, T.; Takenawa, T., 2003:
SKIP, a PIP3 phosphatase, negatively regulates insulin-induced GLUT4 translocation and membrane ruffling formation

Li, Q.; Lavezzi, W.A.; Vincenti, D.M.; Sheehan, C.E.; Ross, J.S.; Carlson, J.A., 2003:
SKP2 and p27 are inversely related in melanoma

Cavalla, P.; Piva, R.; Bosone, I.; Bortolotto, S.; D.V.to, N.; Vercellino, M.; Costanza, A.; Schiffer, D., 2000:
SKP2 immunostaining in high-grade gliomas is associated with p27 degradation

Yokoi Ishihara, S.; Yasui, K.; Saito Ohara, F.; IIzasa, T.; Fujisawa, T.; Terasaki, T.; Horii, A.; Takahashi, T.; Hirohashi, S.; Inazawa, J., 2002:
SKP2 is a novel target within the 5p13 amplicon frequently detected in small cell lung cancers

Armengol, C.; Boix, L.; Sole, M.; Bachs, O.; Bruix, J., 2004:
SKP2 overexpression is associated to reduced P27KIP1 protein levels in human hepatocellular carcinoma

Graabaek, C.A.dersen; Vinge, E.B.ath, 2003:
SKUB-Nurses consultation for women, who have received curative radiation therapy for breast cancer

Calabrese, G.; Morizio, E.; Toro, P.; Taraborelli, T.; Lonardo, F.; Rinaldi, M.M.; D.G.lio, M.C.; Simonelli, A.; Cristini, L.; Fantasia, D.; Gatta, V.; Guanciali, F.P.; Stuppia, L.; Giannotti, A.; Palka, G., 2001:
SKY analysis on 17 constitutional marker chromosomes

Trakhtenbrot, L.; Yukla, M.; Manor, Y.; Cohen, N.; Tangi, I.; Gaber, E.; Amariglio, N.; Amiel, A., 1999:
SKY detection of 11q23 rearrangements in the case of secondary leukemia with a complex karyotype

Karaskova, J.; Bayani, J.; Zielenska, M.; Pandita, A.; A.R.maih, K.; Harrison, K.; Bridge, J.A.; Sorensen, P.; Thorner, P.; Squire, J.A., 2002:
SKY identifies recurrent complex rearrangements involving chromosomes 8, 17 and 20 in osteosarcomas

Hermsen, M.; Snijders, A.; Guervos, M.A.onso; Tanzer, S.; Baak, J.; Pinkel, D.; Albertson, D.; Meijer, G.; Schrock, E., 2002:
SKY, chromosome CGH and array CGH analysis of two types of epithelial tumors Squamous cell carcinoma versus adenocarcinoma

Aubin, N.; Barneoud, P.; Carter, C.; Caille, D.; Sontag, N.; Marc, C.; Lolivier, J.; Gardes, A.; Perron, C.; L.K.m, A.; Charieras, T.; Pandini, M.; Burnier, P.; Puech, F.; Jegham, S.; George, P.; Scatton, B.; Curet, O., 2004:
SL251131 ,3a -3-methoxymethyl-7- -3,3a,4,5-tetrahydro-1,3-oxazolo quinolin-1-one, a new, reversible, and mixed inhibitor of monoamine oxidase-A and monoamine oxidase-B Biochemical and behavioral profile

Griebel, G.; Perrault, G.; Granger, P.; Decobert, M.; Tan, S.; Avenet, P.; Evanno, Y.; Sevrin, M.; George, P.; Schoemaker, H.; Francon, D.; Depoortere, H.; Bergis, O.E.; Scatton, B., 2000:
SL651498 a new anxiolytic with functional selectivity for GABAA2a and GABAA3a receptor subtypes

Griebel, G.; Perrault, G.; Simiand, J.; Cohen, C.; Granger, P.; Depoortere, H.; Françon, D.; Avenet, P.; Schoemaker, H.; Evanno, Y.; Sevrin, M.; George, P.; Scatton, B., 2003:
SL651498, a GABAA receptor agonist with subtype-selective efficacy, as a potential treatment for generalized anxiety disorder and muscle spasms

Herkel, J.; Heidrich, B.; Wies, I.; Lohse, A.W., 2000:
SLA/LP autoantibodies recognize at least three independent epitopes within the dominant antigenic region of the SLA/LP protein

Mavaddat, N.; Mason, D.W.; Atkinson, P.; Evans, E.J.; Gilbert, R.J.C.; Stuart, D.I.; Fennelly, J.A.; Barclay, A.N.; Davis, S.J.; Brown, M.H., 2000:
SLAM self-associates with very low affinity

Lacoux, X.; Dugua, J.M.; Narminio, D.; Vayssie, F.; Dalbon, P.; Jolivet, M., 2002:
SLAM, alkoxyamine/maleimide water soluble heterobifunctional crosslinker, application and derivates

Sheffield, L.J.; Williamson, R.; Halliday, J.L.; Forbes, R.M.; Jaques, A.M.; Cronin, A.; Bonacquisto, L.; Francis, I., 2003:
SLAMDUNC A very successful new community program for first trimester combined screening for Down syndrome

Vernon, D.M.; Brinck, M.D.; Brady, M.A.; Eastberg, J.H.; Forsthoefel, N., 2000:
SLATs A family of Arabidopsis proteins resembling components of the RAS signaling pathway

Allard, P.; Marzluff, W.; Clarke, H., 2003:
SLBP accumulation during meiotic maturation is required for normal histone synthesis in the mammalian egg

Suply, T.; Della Zuana, O.; Audinot, V.; Rodriguez, M.; Beauverger, P.; Duhault, J.; Canet, E.; Galizzi, J.P.; Lebrun, C.; Nahon, J.L.; Levens, N.; Boutin, J.A., 2001:
SLC-1 receptor mediates the effect of melanin concentrating hormone on feeding behaviour in the rat A structure activity study

Barone, S.; Ju, X.; Petrovic, S.; Soleimani, M., 2002:
SLC26A7 is an apical Cl-/HCO3- exchanger in stomach mucous cells and is regulated by gastric acid

Lipovich, L.; Lynch, E.D.; King, M.C.aire, 2000:
SLC4A9 Hypervariable splicing and genomic localization in the EGF-FGF cluster ancestral duplication context

Buccafusca, R.; Wu, S.; Golden, J.; Mcveigh, K.; Berry, G., 2000:
SLC5A3 gene expression regulates fetal myo-inositol levels

Font Llitjos, M.; Cystinuria Consortium, 2000:
SLC7A9 as the main non-Type I cystinuria gene

Leclerc, D.; Boutros, M.; Suh, D.; Wu, Q.; Palacin, M.; Goodyer, P.; Rozen, R., 2000:
SLC7A9 mutations in Type II and Type III cystinuria

Campbell, K.S.; Moss, R.L., 2003:
SLControl PC-based data acquisition for muscle mechanics

Noronha, C.; Galrinho, A.; Panarra, A.; Sousa, M.; Barros, M.J.; Vaz Riscado, M., 2002:
SLE and APS Sometimes a catastrophic combination

Pawlak, C.R.; Jacobs, R.; Ochsmann, S.; Mikeska, E.; Kavelaars, A.; Heijnen, C.J.; Schmidt, R.E.; Schedlowski, M., 2001:
SLE and RA patients differ from healthy controls in their cytokine pattern after acute stress

Buck, A.C.; Serebro, L.H.; Quinet, R.J., 1999:
SLE and abdominal pain Retrospective review and analysis of the literature

Fernanez Romero, D.S.; Scher, U.J.; Paolini, M.V.; Prada, M.E.; Bierfass, G.; D.L.nardo, A.M., 2002:
SLE and acquired inhibitor of the factor VIII

Garcia, M.A.; Marcos, A.I.; Pons Estel, B.; Arturi, A.; Babini, J.; Marcos, J.C., 2001:
SLE in Latinamerican men Clinical and laboratory profile

Mcelhone, K.; Smith, P.; Teh, L.S.an, 2001:
SLE in a cohort of patients

Soriano, E.R.; Catoggio, L.J.; Santos, C.D.; Imamura, P.M.; Alvarellos, A.; Saurit, V.; Jacobelli, S., 2001:
SLE in the elderly A distinct subgroup?

Alarcón, G.S.; McGwin, G.; Bastian, H.M.; Fessler, B.J.; Baethge, B.A.; Friedman, A.W.; Reveille, J.D., 2002:
SLE in three ethnic groups XIII. the 'weighted' criteria as predictors of damage

Mcconnell, J.R.; Crockard, A.D.; Cairns, A.P.; Bell, A.L., 2001:
SLE neutrophils demonstrate increased nuclear DNA fragmentation

Bengtsson, A.A.; Sturfelt, G.; Klint, C.; Truedsson, L., 2003:
SLE serum factors induce apoptosis in monocytes and lymphocytes Relation to complement

Alarcon Segovia, D.; Tumlin, J.; Furie, R.; Mckay, J.; Cardiel, M.; Linnik, M.; Hepburn, B., 2001:
SLE trial shows fewer renal flares in LJP 394-treated patients with high-affinity antibodies to LJP 394 90-05 Trial results

Linker Israeli, M.; Wallace, D.J.; Mengesha, E.; Taylor, K.D.; Fischel Ghodsian, N.; Mueller, C., 2000:
SLE-associated alleles of the IL-6 3 flanking region contribute to IL-6 gene regulation

Linker Israeli, M.; Wallace, D.J.; Mengesha, E.; Taylor, K.; Fischel Ghodssian, N.; Klinenberg, J.R., 1999:
SLE-associated alleles of the IL-6 3 flanking region modulate IL-6 expression

Robson, K.M.rie; Sciascia, S.A.ne; Stetler, D.A., 2001:
SLE-like autoimmune responses in animals immunized with the largest subunit of RNA polymerase I

Prokunina, L.; Castillejo Lpez, C.; Gunnarsson, I.; Berg, L.; Tentler, D.; Oberg, F.; Alarcon Riquelme, M., 2001:
SLEB2 region in human SLE Locus-gene-mutation

Gietka, P.; Wierzbowska, M., 2003:
SLEDAI and ECLAM indexes application in the evaluation of juvenile systemic lupus erythematosus

Mckeage, K.; Scott, L.J., 2003:
Sli-381

Grimaudo, S.; Sevilla, S.; Sarano, J.; Manni, J.A., 2001:
SLICC/ACR damage index in systemic lupus erythematosus patients with long disease duration

Toth, E.L.; Strong, D.; Tennant, M.; Greve, M.; Steinhauer, L.; Shade, S.; I.A.original Diabetes Initiative, 2003:
SLICK in Alberta First Nations

Raevskii, O.A.; Trepalina, E.V.; Trepalin, S.V., 2000:
SLIPPER, new software for calculating solubility, lipophilicity and liposome permeability

Astuti, D.; D.S.lva, N.F.; Dallol, A.; Gentle, D.; Martinsson, T.; Kogner, P.; Grundy, R.; Kishida, T.; Yao, M.; Latif, F.; Maher, E.R., 2003:
SLIT2 promoter methylation analysis in neuroblastoma, Wilms tumours and renal cell carcinoma

Zhang, Y.; Wang, Z.; Zhang, J.; Giles, F.J.; Lim, S.H., 2003:
SLLP1 is a human spermatozoa-specific gene aberrantly expressed in hematologic malignancies

Mandal, A.; Klotz, K.L.; Shetty, J.; Jayes, F.L.; Wolkowicz, M.J.; Bolling, L.C.; Coonrod, S.A.; Black, M.B.; Diekman, A.B.; Haystead, T.A.J.; Flickinger, C.J.; Herr, J.C., 2002:
SLLP1, a novel non-bacteriolytic C lysozyme-like protein in the acrosome of human spermatozoa

Richard, Stephane, 2001:
SLM-1 a novel Sam68-like mammalian protein

Joerg, L.; Tausch, C.; Gruenauer, A.; Panholzer, P.J.; Aufschnaiter, M.; Sega, W.; Langsteger, W., 2000:
SLN biopsy Detection rate in 150 patients with breast cancer

Barros, A.; Piato, J.R.; Nisida, A.C.; Pinotti, J.A.; Pincerato, K.; Vigario, A., 2002:
SLN biopsy in cases of breast carcinomas submitted to neoadjuvant chemotherapy

Bertrand, S.; Smalle, J.; Haegman, M.; Fostier, E.; Van Montagu, M.; Van Der Straeten, D., 2000:
SLO A factor defining an ethylene pathway in parallel to ETR1 and EIN2?

Rosolen, S.G.; Gautier, V.; Saint Macary, G.; L.G.rgasson, J.F., 2000:
SLO angiography Arterio venous filling time on monkeys, minipigs and human

Rosolen, S.G.; Legargasson, J.F.; Saint Macary, G., 1999:
SLO angiography for clinical and toxicological studies on animals

Cohen, S.Y.; Lamarque, F.; Saucet, J.C.; Provent, P.; L.G.rgasson, J.F., 2000:
SLO assessment of filling-in phenomenon in patients with AMD Differences regarding uni- or bilaterality of central scotoma

Wang, Z.W.; Saifee, O.; Nonet, M.L.; Salkoff, L., 2001:
SLO-1 potassium channels regulate duration of neurotransmitter release

Lin, H.C.; Chen, J.H.; Neevel, C., 2003:
SLOWING OF INTESTINAL TRANSIT BY FAT DEPENDS ON AN ADRENERGIC PATHWAY ACTING ON beta1- BUT NOT alpha-ADRENORECEPTORS

Mizuno, K.; Watanabe, N.; Ogimoto, M.; Yakura, H., 2003:
SLP-76 is dephosphorylated by SHP-1 and regulates BCR-mediated signaling in B cells

Guerette, G.; Martin, M.; Raab, M.; Rudd, C.E., 1999:
SLP-76 is involved in CD28 signaling

Mizuno, K.; Watanabe, N.; Ogimoto, M.; Yakura, H., 2004:
SLP-76, a Substrate for SHP-1, Regulates BCR-induced JNK Activation

Ino Oka, N.; Ebina, M.; Shimizukawa, M.; Abe, T.; Fukumoto, M.; Fujimura, S.; Nukiwa, T., 1999:
SLPI and IL-10 as possible armaments for non-small cell lung cancer against anti-cancer immunoreactions

Schulze, H.; Korpal, M.; Bergmeier, W.; Italiano, J.E.J.; Wahl, S.M.; Wagner, D.D.; Shivdasani, R.A., 2003:
SLPI is a beta1-tubulin binding protein that is expressed in megakaryocytes and platelets

Maher, T.A.; Baldwin, C.T.; Zhao, G.; Milunsky, A.; Milunsky, J.M., 2003:
SLUG is not a common cause of Waardenburg syndrome type 2

Seidel, M.G.; Inoue, A.R.; Look, A.T., 2000:
SLUG, a leukemogenic zinc finger transcriptional repressor inhibits apoptosis in hematopoietic progenitors

Tsuji, H.; Okamoto, K.; Tamiya, G.; Inoko, H.; IIzuka, H., 2004:
SLURP-2, a novel member of LY-6 superfamily that is up-regulated in psoriasis vulgaris

D.V.ies, M.H.; Hesselink, M.B.; Winsemius, A.A.; Jenner, P.; Johnston, L.; Salvage, S., 2004:
SLV 308 Plasma levels of effective doses in MPTP-treated marmosets in comparison with plasma levels and D2 receptor occupancy in humans

Sorbera, L.A.; Leeson, P.A.; Castaner, J., 2002:
SLV-306 Antihypertensive, treatment of heart failure, neprilysin inhibitor, endothelin-converting enzyme inhibitor

Kuc, R.E.; Ashby, M.J.; Seed, A.; Passier, P.; Essers, H.; Mcmurray, J.J.V.; Davenport, A.P., 2002:
SLV306, a novel endothelin converting enzyme and neutral endopeptidase inhibitor prevents systemic conversion of infused big endothelin-1 in humans

Mccreary, A.C.; Ronken, E.; Herremans, A.; V.D.H.yden, J.; Tuinstra, T.; V.S.harrenburg, G.; Hesselink, M.; Long, S., 2001:
SLV308 A novel antiparkinsonian agent with antidepressant and anxiolytic efficacy

Johnston, L.C.; Smith, L.; Mccreary, A.C.; Jenner, P.; Ronken, E., 2001:
SLV308 Antiparkinsonian effects in the MPTP-treated common marmoset

Feenstra, R.; Ronken, E.; Koopman, T.; D.V.ies, M.; Mccreary, A.; Stoker, M.; Van Charldorp, K.; Long, S.; Van Scharrenburg, G., 2001:
SLV308 Antiparkinsonian, antidepressant, anxiolytic, dopamine D2 partial agonist, 5-HT1A agonist

Hesselink, M.; Siarey, R.; Glennon, J.; Ronken, E.; V.S.harrenburg, G.; Mccreary, A.; Long, S., 2001:
SLV308, a molecule combining potent partial dopamine D2 receptor agonism with serotonin 5-HT1A receptor agonism In vitro and in vivo neurochemistry

Ridger, V.C.; Hellewell, P.G.; Norman, K.E., 2002:
SLex can mediate rolling on P-selectin only in combination with L-selectin

Matsumoto, R.R.; Mack, A.L., 2001:
(+/-)-SM 21 attenuates the convulsive and locomotor stimulatory effects of cocaine in mice

Lieb, M.E.; Moschella, M.C.; Taubman, M.B., 1999:
SM-20 is part of a mulitigene family with differing patterns of expression in mouse tissues

Mimoto, T.; Nojima, S.; Terashima, K.; Takaku, H.; Chiba, N.; Shintani, M.; Yamaoka, T.; Hayashi, H., 2003:
SM-309515 A novel and promising HIV protease inhibitor with favorable pharmacokinetics and resistance profiles

Babu, G.J.; Pyne, G.J.; Huke, S.; Osol, G.; Low, R.; Paul, R.J.; Periasamy, M., 2001:
SM-B myosin isoform is a critical determinant of smooth muscle contractility

Mohamed, S.; Jadhav, P.K.; Batt, D.; Mousa, S.A., 2000:
SM256, a novel non-peptide and potent integrin antagonist for vascular cell integrin alphavbeta3 potently inhibit angiogenesis-mediated disorders

Matsubara, M.; Shyoguchi, E.; Satoh, N.; Akasaka, K.; Komatsu, M.; Wada, H., 2002:
SM50 transcriptional regulation mechanism and the evolution of spicule in echinoderm

Vial, E.; Burlet, P.; Viollet, L.; Munnich, A.; Lefebvre, S., 2001:
SMA carrier detection using Taqman technology Implications for genetic counseling

Vial, E.; Burlet, P.; Raclin, V.; Viollet, L.; Bertrandy, S.; Munnich, A.; Lefebvre, S., 2000:
SMA carrier detection using real-time quantitative TaqMan polymerase chain reaction

Prior, T.W.; Parsons, D.W.; Heinz, J.W.; Papp, A.C.; Schafer, R.W.; Sedra, M.S.; Snyder, P.J.; Burghes, A.H.M.; Mcandrew, P.E., 1999:
SMA carrier testing The Ohio State University experience

Lorentz, O.; Fintz, A.C.; Sahel, J.A.; Leveillard, T., 2001:
SMAD signaling and cone photoreceptor survival

Huang, X.R.; Li, J.H.; Chen, Y.X.; Johnson, R.J.; Lan, H.Y., 2001:
SMAD signaling, a novel pathway of angiotensin II-induced renal fibrosis

Lazzereschi, D.; Turco, A.; Nardi, F.; D'amico, C.; Ottini, L.; Coppa, A.; Colletta, G., 2000:
SMAD-4/DPC4 suppressor gene deregulation can occur at multiple levels in thyroid tumour development

Nakano, H.; Vindevoghel, L.; Kouba, D.J.; Uitto, J.; Mauviel, A., 1999:
SMAD-dependent regulation of type I collagen gene expression

Cesi, V.; Sesti, F.; Tanno, B.; Vitali, R.; Giuffrida, M.L.ura; Mancini, C.; Raschella, G., 2003:
SMAD/Sp network regulates IGFBP-5 transcription

Siegel, R.E.; Angley, C.; Kumar, M.; Dinsio, K.J.; Hall, A.K., 2001:
SMAD1 and BMP4 expression in the rat cerebellum increase transiently during postnatal maturation

Weinstein, M.; Monga, S.P.S.; Rashid, A.; Mishra, L.; Deng, C.X., 1999:
SMAD2/3 deficiency defines an essential developmental checkpoint in liver formation

Minoo, P.; Li, C.; Zhu, N.; Ballard, P., 2001:
SMAD3 mediates TGF-beta induced repression of surfactant protein-B gene expression

Royce, S.G.; Alsop, K.J.; Haydon, A.M.; Jenkins, M.A.; Mead, L.J.; Giles, G.G.; Hopper, J.L.; Southey, M.C., 2003:
SMAD4 tumor suppressor in early onset colorectal cancers

Espinosa Parrilla, Y.; Encha Razavi, F.; Atti Bitach, T.; Gosset, P.; Munnich, A.; Vekemans, M.; Lyonnet, S.; Amiel, J., 2002:
SMADIP1 is not a major gene in isolated agenesis of the corpus callosum

Monzen, K.; Shiojima, I.; Hiroi, Y.; Kudoh, S.; Oka, T.; Takimoto, E.; Hayashi, D.; Hosoda, T.; Mizukami, M.; Kawabata, M.; Miyazono, K.; Komuro, I., 1999:
SMADs are required for bone morphogenetic protein-induced cardiomyocyte differentiation in P19 teratocarcinoma cells

Taimor, G.; Schneiders, D.; Heger, J.; Piper, H.M.chael, 2003:
SMADs mediate nitric oxide induced apoptosis in cardiomyocytes

Gramley, F.; Schauerte, P.; Gressner, A.; Lorenzen, J., 2003:
SMADs mediate structural remodeling in fibrillating atria

Maeda, H., 2001:
SMANCS and polymer-conjugated macromolecular drugs: advantages in cancer chemotherapy

Chaker, A.; Gentile, M.; Salahuddin, S.; Yano, X.; Drews, R.; Yunis, E.J.; Schnitt, S.J.; Schnipper, L.E., 2004:
SMARCAD1 interacts with proteins involved in the processes of transcriptional activation, DNA replication and repair mechanisms

Adra, C.; Carlo, V.; Badovinac, R.; Hairston, J.; Yang, X.; Yano, Y.; Shirakawa, T.; Drews, R.; Schnitt, S.; Schnipper, L., 2003:
SMARCAD1 protein is under expressed in invasive breast cancer

Hejmanowski, A.Q.; Burghes, A.H.M.; Prior, T.W., 2002:
SMARD gene scan in patients with non-5q SMA

Amosson, C.M.; Teh, B.S.; Van, T.; Uy, N.W.; Huang, E.; Mai, W.; Woo, S.Y.; Chiu, J.K.; Carpenter, L.S.; Lu, H.H.; Grant, W.H.; Butler, E.B., 2002:
SMART boost technique-correlation of subjective xerostomia and dosimetric parameters of the parotid glands

Joo, C.H.; Lee, H.; Kim, E.; Lee, B.; Cho, Y.K.; Kim, Y.K., 2001:
SMART-PCR A novel RT-PCR method to detect active cytomegalovirus infection

Marchand, E.L.ne; Der Sarkissian, S.; Hamet, P.; Deblois, D., 2001:
SMC apoptosis A sudden, transient and caspase-dependent event mediating aortic hypertrophy regression in losartan-treated hypertensive rats

Yokomori, K., 2003:
SMC protein complexes and the maintenance of chromosome integrity

Liu, Z.; Xu, Y.; Tang, P., 2004:
SMD simulations of Na+ permeation across gramicidin A channel

Carroll, Steven, L., 2003:
SMDF and GGF neuregulin splice variant isoforms and uses thereof

Bai, R.Y.; Ouyang, T.; Miething, C.; Hahn, S.; Peschel, C.; Duyster, J., 2000:
SMIF, a novel Smad-4-interacting protein acts as a crucial transcription activator in TGF-beta signaling

Coady, M.J.; Wallendorf, B.; Gagnon, D.G.; Lapointe, J.Y.es, 2002:
SMIT2 is a novel renal Na+/myo-inositol cotransporter

Narayanan, U.; Ospina, J.K.; Matera, A.G., 2002:
SMN forms a pre-import snRNP complex with snurportin and importin beta

Cusin, V.; Clermont, O.; Chantereau, D.; Gerard, B.; Bingen, E.; Elion, J., 2002:
SMN mutations screening in non deleted SMA patients

Burlet, P.; Bertrandy, S.; Martinovic, Y.; Vekemans, M.; Munnich, A.; Lefebvre, S., 1999:
SMN protein is associated to large cytoplasmic dot-like structures in human fetal muscles

Anonymous, 2002:
SMN1 studies

Schwartz, M.; Hansen, F.J.ul, 2003:
SMN2 copy-number in the prognosis of spinal muscle athrophy

Burlet, P.; Via, E.; Viollet, L.; Huber, C.; Munnich, A.; Lefebvre, S., 2001:
SMN2 gene stimulations give differential expression in SMA and control cultured cells

Anonymous, 2002:
SMN2 studies

Ryan, A.M.; Hagler, K.E.; Luoh, S.M.; Desauvage, F.J., 1999:
SMO mutations and basal cell carcinoma in transgenic mice

Scornik, F.S.; Barstow, K.L.; Parsons, R.L., 2001:
SMOCs modulate excitability of mudpuppy parasympathetic neurons

Chung, Y.J.; Moreno, M.S.; Jack, D.L.; Maile, R.R.; Weyler, W.; Saier, M.H., 2001:
SMR-type multidrug efflux pumps of Bacillus subtilis

Elateri, I.; Snyder, C.; Lynch, F.; Muller Weeks, S.; Caradonna, S.J., 2001:
SMUG1 Characteristics of a newly discovered uracil-DNA repair enzyme

Gehr, Peter, 2004:
SMW Young Investigators Award 2003 Clustering of cardiovascular risk factors mimicking the human metabolic syndrome X in eNOS null mice

Dallinger, G.; Puttaraju, M.; Mitchell, L.; Yancey, K.; Klausegger, A.; Hintner, H.; Bauer, J., 2001:
SMaRT repair of collagen 17A1 mRNA Semi-quantitative PCR analysis of cis- vs trans-splicing

Dávila-Martínez, Y.; Ramos-Vega, A.Laura.; Contreras-Martínez, S.; Encarnación, S.; Geiger, O.; López-Lara, I.M., 2010:
SMc01553 is the sixth acyl carrier protein in Sinorhizobium meliloti 1021

Lien, E.L.; Yuhas, R.J.; Mason, S.M.; Boyle, F.G., 2001:
SN-2 palmitic acid is only a partial explanation for fat absorption levels in rats fed infant formula fat blends

Minderman, H.; Greco, W.R.; Conroy, J.; O'loughlin, K.L.; Mcquaid, D.; Quinn, P.; Nowak, N.; Baer, M.R., 2003:
SN-38-induced kinetic changes in transcription of cell cycle regulatory genes in HL60 cells

Takahashi, K.I.hi; Krizaj, D.; Copenhagen, D.R., 2003:
SN1 catalyzes transport of glutamine across Muller cells in retina

Wu, X.W.; Hollemweguer, E.; Chen, Z., 2000:
SN2 A monoclonal antibody to CD165 induces platelet activation

Nakakoshi, M.; Kimura, K.; Nakajima, N.; Yoshihama, M.; Uramoto, M., 1999:
SNA-4606-1, a new member of elaiophylins with enzyme inhibition activity against testosterone 5 alpha-reductase

Hybarger, S.E.; Sloan, T.B., 2003:
SNAP Index with Light Anesthesia and MAC during Surgery

Polgar, J.; Lane, W.S.; Chung, S.H.e; Reed, G.L., 2003:
SNAP-23 is phosphorylated in thrombin-activated human platelets with kinetics that precede or parallel granule secretion

Wang, P.; Liu, L., 2004:
SNAP-23 is required for annxin II-mediated fusion of lamellar bodies with the plasma membrane

Schriever Abeln, J.; Ma, X.; Eliasson, L., 2002:
SNAP-25 and Syntaxin 1 reduce exocytosis of insulin-containing granules in pancreatic beta-cells

Barr, C.L.; Feng, Y.; Wigg, K.; Bloom, S.; Roberts, W.; Malone, M.; Schachar, R.; Tannock, R.; Kennedy, J.L., 2000:
SNAP-25 and attention-deficit hyperactivity disorder

Schriever Abeln, J.; Ma, X.; Eliasson, L., 2001:
SNAP-25 and syntaxin influence the readily releasble pool of insulin-containing granules in mouse pancreatic B-cells

Jellies, J.A.; Smith, T.; Johansen, J.; Johansen, K.M., 2001:
SNAP-25 immunoreactivity in developing neurons and synaptic neuropil of embryonic leech

Gonelle Gispert, C.; Costa, M.; Takahashi, M.; Sadoul, K.; Halban, P.A., 2001:
SNAP-25 phosphorylation in insulin secreting cells

Mochida, S.; Su, Q.; Sheng, Z.H.ng, 2003:
SNAP-29 inhibits SNARE disassembly at presynaptic nerve terminals

Su, Q.; Mochida, S.; Sheng, Z.H.ng, 1999:
SNAP-29, a syntaxin 1A-binding protein implicated in synaptic transmission

Chien, L.Y.n; Whyte, R.; Thiessen, P.; Lee, S., 2000:
SNAP-II predicts resource use in the NICU

Newton, N.R.; Miller, S.P.; Ferriero, D.M.; Kaufman, S.A.; Barkovich, A.J.mes; Partridge, J.C.lin, 2001:
SNAP-PE as a predictor of neurodevelopmental outcome at 1 and 25 years of age following perinatal depression

Ji, J.; Huang, X.; Trimble, W.S.; Salapatek, A.M.F.; Gaisano, H.Y., 1999:
SNAP25 protein modulation of L-type Ca2+ channels in insulinoma HIT-T15 betacells

Lai, K.Crane.; Flaumenhaft, R., 2002 :
SNARE protein degradation upon platelet activation: calpain cleaves SNAP-23

Washbourne, P.E.; Lezcano, N.; Montecucco, C.; Burgoyne, R.D.; Wilson, M.C., 1999:
SNARE assembly Syntaxin is sufficient to direct targeting of SNAP-25 to the membrane

Slind, J.; Ganetzky, B.; Littleton, J.T., 2000:
SNARE complex disassembly by NSF following synaptic vesicle fusion

Hay, J.C., 2001:
SNARE complex structure and function

Bryant, N.J.; Gerrard, S.R.; James, D.E.; Stevens, T.H., 2000:
SNARE complexes in the yeast endosomal system

Xia, Z.; Zhou, J.; Liu, Y., 2000:
SNARE function in exocytosis studied by fluorescence resonance energy transfer

Kavalali, E.T., 2002:
SNARE interactions in membrane trafficking: a perspective from mammalian central synapses

Logan, M.R.; Odemuyiwa, S.O.; Davoine, F.; Steward, M.; Lacy, P.; Moqbel, R., 2004:
SNARE isoforms in granule-derived mediator secretion from human eosinophils and neutrophils A conserved mechanism for granule docking?

Linial, Michal, 2001:
SNARE proteins From membranes to genomes

Augustine, George, J., 1999:
SNARE proteins and neurotransmitter release A functional view

Maianu, L.; Garvey, W.T.mothy, 2001:
SNARE proteins and skeletal muscle insulin resistance in rats and humans

Andrews, P.M.; Fernandez Llama, P.; Inoue, T.; Knepper, M.A., 1999:
SNARE proteins in kidney juxtaglomerular cells

Saxena, S.; Bens, M.; Warnock, D.G.; Vandewalle, A.; Tousson, A., 2002:
SNARE proteins physically interact and modulate epithelial sodium channel function in mpkCCDc14 cells

Martic, M.; Liu, D.Y.; Dunlop, M.E.; Baker, H.W.G., 2000:
SNARE proteins, syntaxin and Munc-18 are present in human spermatozoa

Cousin, M.; Apps, D.; Shipston, M.; Chow, B., 2001:
SNAREdinburgh: the molecular mechanisms of exocytosis and endocytosis

Espiritu, D.J.y D.; Bernardo, A.A.; Arruda, J.A.L., 2003:
SNAREs play a role in AII-induced Na+/HCO3-cotransporter translocation to the basolateral membrane

Zhu, J., 1999:
S(N)Ar-based cycloetherification methodology: application in the synthesis of heterodectic macrocyclic peptides with endo aryl-aryl and aryl-alkyl ether bonds

Warmflash, D.M.; Clemett, S.J.; Mckay, D.S., 2001:
SNC meteorites, organic matter and a new look at Viking

Okura, T.; Cowell, S.M.; Varga, E.; Burkey, T.H.; Roeske, W.R.; Yamamura, H.I., 2000:
SNC80 specific down-regulation of the human delta-opioid receptor truncated at Gly338

Winkfield, B.; Oberti, F.; Aube, C.; Vuillemin, E.; Rousselet, M.C.ristine; Cales, P., 2002:
SNCF A non invasive score to reduce the false negative rate of liver biopsies for cirrhosis

Brock, M.W.; Gilly, W.F., 1999:
SNDTT block of shaker potassium channels Evidence for escape from a trap

Esumi, Y.; Suzuki, Y.; Ichikawa, T.; Ikeda, Y.; Kimura, K-ichi., 2003:
SNF-4794: new enzyme inhibitors produced by Chaetomella sp

Zhang, Q.; Jair, K.W.ng; Lee, D.W.; Raabe, E.; Sun, L.Q.an; Baylin, S.B.; Arceci, R.J., 2003:
SNF2 family member, PASG , interacts with and augments methyltransferase-mediated DNA methylation

Chrivia, J.; Yaciuk, P., 2002:
SNF2 related CBP activator protein

Sumi Ichinose, C.; Ichinose, H.; Metzger, D.; Tazawa, M.; Ohtsuki, M.; Nomura, H.; Nagatsu, T.; Nomura, T.; Hagino, Y.; Chambon, P., 1999:
SNF2beta-BRG1 is essential for the viability of F9 murine embryonal carcinoma cells

Ishikawa, Y.; Skowronski, M.; Eguchi, T.; Ishida, H., 1999:
SNI-2011 acts on M3-receptors and induces the long-lasting increase in the amount of aquaporin5 in the apical plasma membrane of rat parotid glands

Stanford, W.L.; Cohn, J.; Bernstein, A., 2000:
SNL-1, a novel hematopoietic and vascular gene required for embryonic development

Omotade, A.O., 2003:
SNMA's presidential initiative: mental health and minority communities

Baxter, D.A.; Chen, H.; Cai, Y.; Malik, A.; Susswein, A.J.; Byrne, J.H., 2001:
SNNAP A general purpose simulator for neural networks and action potentials

Balla, J.; Lepej, J.; Keleova, A., 1999 :
SNOLAMED A new Systematized Nomenclature in Laboratory Medicine and Clinical Support Services in Slovakia

Liu, C.; Gershon, E.S., 2001:
SNP Cruncher A perl script toolbox for large-scale SNP data mining

Gelfand, C.A.; Scott, K.E.; Varde, S.A., 2002:
SNP allele frequency determined for pooled samples in multiplexed assays

Higuchi, R.; Germer, S.; Holland, M.J., 1999:
SNP allele-frequency determination in pooled DNA samples by kinetic PCR

Lohmussaar, E.; Zernant, J.; Magi, R.; Kepp, K.; Puurand, T.; Tonisson, N.; Valvas, I.; Slavin, G.; Andreson, R.; Kurg, A.; Remm, M.; Metspalu, A., 2002:
SNP analysis and linkage disequilibrium map of the human chromosome 22 using APEX arrays

Lohmussaar, E.; Zemant, J.; Magi, R.; Puurano, T.; Tonisson, N.; Valves, I.; Slavin, G.; Kurg, A.; Remm, M.; Metspalu, A., 2002:
SNP analysis and linkage disequilibrium map of the human chromosome 22 using Arrayed Primer Extension technology

Ahmadian, A.; Russom, A.; Andersson, H.; Uhlén, M.; Stemme, G.; Nilsson, P., 2002:
SNP analysis by allele-specific extension in a micromachined filter chamber

Ahmadian, A.; Andersson, H.; Van Der Wijngaart, W.; Lundeberg, J.; Uhlen, M.; Stemme, G.; Nilsson, P., 2000:
SNP analysis by pyrosequencing in a micromachined flow-through filter-chamber

Tsigelny, I.F.; Kotlovyi, V.; Wasserman, L., 2004:
SNP analysis combined with protein structure prediction defines structure-functional relationships in cancer related cytochrome P450 estrogen metabolism

Lukowiak, A.A.; Hall, J.G.; Lyamichev, V.I.; Neri, B.P., 2001:
SNP analysis from ultra low levels of human genomic DNA using a homogeneous Invader /PCR assay

Menold, M.M.; Bass, M.P.; Gilbert, J.R.; Wolpert, C.M.; Donnelly, S.L.; Poole, C.W.; Shao, Y.J.; Ravan, S.A.; Mcclain, C.; Von Wendt, L.; Zimmerman, A.; Wright, H.H.; Abramson, R.K.; Delong, G.R.; Cuccaro, M.L.; Pericak Vance, M.A., 2000:
SNP analysis of GABAA receptor subunit in autistic disorder

Menold, M.; Bass, M.P.; Wolpert, C.M.; Donnelly, S.L.; Poole, C.; Abramson, R.K.; Wright, H.H.; Raven, S.A.; Delong, G.R.; Pericak Vance, M.A., 2000:
SNP analysis of GABRB3 in autistic disorder

Sun, H.; Zhao, J.; Du, W.; Wang, H.; Zuo, J.; Qiang, B.; Shen, Y.; Yao, Z.; Huang, W.; Chen, Z.; Xiong, M.; Fang, F., 2002:
SNP analysis of candidate genes associated with type 2 diabetes in Chinese Han population

Ingersoll, R.; Rowe, S.; Campbell, M.; Kasch, L.; Mcintosh, I.; Beaty, T.; Scott, A.F., 2001:
SNP analysis of candidate genes for isolated cleft lip and palate

Metspalu, A.; Zernant, J.; Lohmussaar, E.; Magi, R.; Kepp, K.; Puurand, T.; Tonisson, N.; Valvas, I.; Pavel, H.; Slavin, G.; Andreson, R.; Kurg, A.; Remm, M., 2001:
SNP analysis of the human chromosome 22 using APEX arrays

Nowotny, P.; Kwon, J.M.; Goate, A.M., 2001:
SNP analysis to dissect human traits

Lohmusaar, E.; Landi, S.; Cox, D.; Tonisson, N.; Zernant, J.; Kurg, A.; Canzian, F.; Metspalu, A., 2001:
SNP analysis using arrayed primer extension on the oligonucleotide array Method, hardware, software and results

Morris, A.; Lawrence, R.; Cardon, L., 2002:
SNP ascertainment is a crucial factor in determining LD block structure

Dodge, A.H.; Dailey, D.; Dong, P.; Rhodes, M.; Smith, L.; D.L.V.ga, F.; Spier, G.; Walworth, C.; Gilbert, D., 2002:
SNP assays to enable high throughput genomics

Chen, Y.S.; Akula, N.; Schulze, T.G.; Potluri, S.; Mcmahon, F.J., 2001:
SNP density requirements in mapping genes for complex diseases

Arnold, L.J.; Theriault, T.P.; Bedilion, T., 2002:
SNP detection

Ribas, G.; Neville, M.; Campbell, R.D., 2001:
SNP detection by DHPLC in genes in the MHC class III region encoding novel cell surface molecules

Stevens, P.W.lkins; Hall, J.; Lyamichev, V.; Neri, B.; Kelso, D., 2001:
SNP detection on solid surface using the Invader assay

Tonks, S.; Bartlett, S.M.; Curtis, L.J.; Bodmer, J.G.; Bodmer, W.F., 2001:
SNP detection without gels

Chen, D.C.; Royer, S.; Nieto, S.; Lin, H.; Butler, J.M.; Monforte, J.A., 1999:
SNP determination using cleavable primers and time-of-flight mass spectrometry

Twyman, R.M., 2004:
SNP discovery and typing technologies for pharmacogenomics

Jones, H.; Vincent, G.; Wynne, J.; Carey, A., 2000:
SNP discovery by direct sequencing using MegaBACE 1000

Tessanne, K.J.; Gregory, K.E.; Kirkpatrick, B.W., 2002:
SNP discovery in candidate genes for a bovine ovulation rate QTL

Sunyaev, S.R.; Lathe, W.C.; Ramensky, V.E.; Bork, P., 2000:
SNP frequencies in human genes an excess of rare alleles and differing modes of selection

Kraus, C.; Krumbiegel, M.; Reis, A., 2003:
SNP frequency, haplotype structure and linkage disequilibrium in human FBN1-gene

Bray, M.S.; Boerwinkle, E.; Doris, P.A., 2001:
SNP genotyping by MALDI-TOF mass spectrometry

Schmidt, D.; Hummel, S., 2003:
SNP genotyping for identification of hair colors from degraded DNA

Panguluri, R.C.K.; Chen, W.; Kittles, R.A., 2002:
SNP genotyping of candidate genes for complex diseases using a novel genotyping platform

Grant, S.F.A.; Tolle, R., 2001:
SNP genotyping on genome wide amplified DOP-PCR template

Hayashibara, K.; Wenz, M.; Koehler, R.; D.L.V.ga, F.; Ridzon, D.; Paner, T., 2001:
SNP genotyping on universal DNA microarrays using multiplexed oligonucleotide ligation assays

Moore, J.M.; Blumenstiel, B.; Chanoux, R.; Defelice, M.; Faggart, M.; Goyette, M.; Lochner, A.; Nguyen, H.; Stahl, E.; Winchester, E.; Ziaugra, L.; Altshuler, D.; Gabriel, S.B., 2003:
SNP genotyping production for the WICGR hap map project

Straub, R.E.; Cesare, A.J.; Harris Kerr, C.; Jiang, Y., 2000:
SNP genotyping using the HEFPTM platform Optimization, accuracy, and cost

Purcell, S.M.; Daly, M.J.; Sham, P.C., 2003:
SNP haplotype analysis for qualitative and quantitative traits in unrelated individuals and parent-offspring trios

Mckenzie, C.A.; Adeyemo, A.; Sinsheimer, J.S.; Bouzekri, N.; Southam, L.; Hugill, A.; Zhu, X.; Forrester, T.E.; Cooper, R.; Cox, R.D.; Lathrop, G.M., 2001:
SNP haplotypes in the angiotensin I-converting enzyme Analysis of Nigerian family data using gamete competition models

Jones, S.H.; Nelson, D.L., 2000:
SNP identification and haplotype studies at BRCA2

Roberts, P.S.; Chung, J.; Jozwiak, S.; Dabora, S.L.; Nieto, A.; Perez, R.; Franz, D.; Thiele, E.; Kwiatkowski, D.J., 2001:
SNP identification, linkage disequilibrium , and maternal origin of mutations within the TSC2 gene

Wai, H.H.; Oda, R.M., 2001:
SNP identification, validation, and scoring with the multi-functional CEQTM 2000XL DNA Analysis System

Armengol, L.; Gratacos, M.; Perez, G.; Bulbena, A.; Martin Santos, R.; Estivill, X., 2001:
SNP in the 5 region of the NTRK3 gene is associated with panic disorder

Liu, C.; Nguyen, T.; Zhang, R.; Yao, F.; Zhu, Z.; Gershon, E.S., 2003:
SNP information mining pipeline for complex disease studies

Dow, D.; Devitt, P.J.; Candlin, A.; Gray, I.C.; Barnes, M.R., 2002:
SNP locator A bioinformatics tool for determining the distance between SNPs as an aid to linkage disequilibrium mapping

Abel, K.J.; Whitacre, J.; Sripichai, O.; Erlich, P.; Farrer, L.; Braun, A.; Fucharoen, S., 2003:
SNP map and haplotype analysis of the beta-globin gene region in beta0-thal/HbE patients

Jawaid, A.; Sham, P.; Makoff, A.; Asherson, P., 2002:
SNP marker selection for association mapping of complex traits

Sarkar, N.; Kashyap, V.K., 2003:
SNP markers in forensic testing A preliminary study

Wypgant, M., 2002:
SNP market view: opportunities, technologies, and products

Flores Villanueva, P.O.; Palha, J.A.; Mcalister, C.; Dobesova, L.M.; Belmonte, D.A.reu, P.; Ruano, D.; Macedo, A.; Dourado, A.; Soares, M.; Valente, J.; Azevedo, M.H.; Yunis, E.; Faraone, S.V.; Tsuang, M.T.; Goodman, A.B., 2002:
SNP of retinoid X receptor B at chromosome 6p213 associated with schizophrenia

Werner, M.; Altmueller, J.; Herbon, N.; Wjst, M., 2002:
SNP scanning in pooled DNA A chance for rapid case-control-studies

Spangberg, L.; Erickson, K.; Jonsson, J.; Gad, P.; Henriksson, J., 2000:
SNP scoring by one base sequencing

Dale, S.; Bamford, A.; Briggs, J.; Cuss, S.; Horsey, I.; Kent, L.; Kingsmore, S.; Knott, T.; Lasken, R.; Pickering, J.; Shipstone, E.; Strong, C., 2000:
SNP scoring studies using the snipertm rolling circle amplification-based system

White, P.S.ott; Cai, H.; Torney, D.C.; Nolan, J.P., 2001:
SNP scoring technologies Why are there so many?

Tonks, S.; Kim, J.C.; Bodmer, W.F., 2003:
SNP screening of a Korean population using alkaline-mediated differential interaction

Katoh, T.; Tounai, K.; Mano, S.; Ando, H.; Munkhbat, B.; Munkhtuvshin, N.; Tokunaga, K.; Jia, G.; Inoko, H.; Tamiya, G., 2003:
SNP variation in a non-coding region of Xq133 in East Asia

Cantor Chiu, R.M.; Yuan, J.; Shimizu, C.; Cheng, S.; Steiner, L.; Shike, H.; Napier, S.L.; Newburger, J.W.; Burns, J.C., 2003:
SNP, cSNP and indel associations with Kawasaki disease susceptibility and outcomes

Orpana, A.; Pajukanta, P.; Palotie, A.; Peltonen, L., 2001:
SNP-TRAP, a simplified method for detecting SNPs

Lohmussaar, E.; Lushnikov, A.; Tonisson, N.; Nikopensius, T.; Kask, I.; Kurg, A.; Metspalu, A., 2001:
SNP-based genotyping using Arrayed Primer Extension on the oligonucleotide array

Ennis, S.; Collins, A.; Morton, N.E., 2003:
SNP-based haplotypes and LD blocks in the fragile X region

Morisaki, H.; Inoue, E.; Kitamura, Y.; Kamatani, N.; Morisaki, T., 2003:
SNP-haplotype analysis in human chromosome region 3q27 in Japanese and European Americans

Hwang,J.Y.; Park,J.E.; Choi,Y.J.; Huh,K.B.; Kim,W.Y., 2010:
SNP276G T polymorphism in the adiponectin gene is associated with metabolic syndrome in patients with Type II diabetes mellitus in Korea

Gonzalez Sanchez, J.L.; Martinez Larrad, M.T.; Fernandez Perez, C.; Lopez, A.; Laakso, M.; Serrano Rios, M., 2003:
SNP45/SNP276 of adiponectin gene in the general population of Spain

Yeager, M.; Packer, B.; Miller, E.; Welch, R.; Kiley, M.; Burke, M.; Crenshaw, A.; Strausberg, R.; Rothman, N.; Chanock, S.J., 2003:
SNP500Cancer database Sequence validation and assay optimization of candidate gene SNPs for molecular epidemiology studies in cancer

Yeager, M.; Packer, B.; Miller, E.; Welch, R.; Kiley, M.; Burke, M.; Strausberg, R.; Rothman, N.; Chanock, S., 2002:
SNP500Cancer database and candidate SNP approach to genetic association studies

Knight, A.; Udina, I.G.; Henn, B.M.; Underhill, P.A.; Mountain, J.L., 2003:
SNPSTR autosomal genohaplotypes by restriction site engineering Empirical gametic phase without allele-specific primers

Jobin, M.J.; Underhill, P.; Lin, A.; Knight, A.; Cavalli Sforza, L.L.; Mountain, J.L., 2001:
SNPSTRs Inferring human evolutionary history from tightly-linked autosomal polymorphisms

Mulcahy, T.M.; Kunkel, M.A.; Greeny, D.; Liberchuk, R.; Camisa, A.; Studebaker, J.; Gelfand, C.A.; Bell, P.A.; Boyce Jacino, M., 2001:
SNPStream MT, a microsphere-based, primer extension system for the analysis of single nucleotide polymorphisms

Weckx, S.; D.R.jk, P.; Van Broeckhoven, C.; Del Favero, J., 2002:
SNPbox A software package for the construction of genome wide high density SNP maps

Carlson, C.S.; Newman, T.L.; Nickerson, D.A., 2001:
SNPing in the human genome

Giardina, E.; Capon, F.; Tacconelli, A.; Chimenti, S.; Zambruno, G.; Novelli, G., 2002:
SNPing of LOR gene in psoriasis patients

Nickerson, Deborah, A., 2003:
SNPing pathways in the human genome

Simmons, Christopher, 2001:
SNPs A novel, efficient approach to genetic analysis

Mountain, Joanna, L., 2001:
SNPs Lessons learned from RFLPs regarding differentiation among human populations, age of mutations, and the impact of ascertainment procedures

Stange, Eduard, F., 2002:
SNPs Sorry, not predictive

Mochida, K.; Kawaura, K.; Yamazaki, Y.; Shin, I.; Tadasu; Kohara, Y.; Ogihara, Y., 2003:
SNPs analysis of hexaploid wheat IV Discovery and validation of SNPs in hexaploid wheat

Sklar, P.; Bolk, S.; Willour, V.; Bennett, P.; Hirschhorn, J.N.; Burtt, N.; Tsan, G.; Jones, I.; Kirov, G.; Owen, M.J.; Craddock, N.; Mcinnis, M.; Depaulo, D.R.; Lander, E., 2000:
SNPs and bipolar disorder Discovery and genotyping

Sklar, P., 2000:
SNPs and neuropsychiatric disorders Discovery and genotyping

Flodman, P.; Macula, A.J.; Moyzis, R.K.; Spence, M.A.; Torney, D.C., 2001:
SNPs and the analysis of complex disease genetics

Shi, J.; Shi, Z.; Gu, B.; Huang, W.; Chen, S.; Chen, Z., 2002:
SNPs in Deoxycytidine Kinase Gene and Their Association with the Treatment Response among the Acute Myeloid Leukemia Patients

Ogorelkova, M.S.; Kraft, H.; Ehnholm, C.; Utermann, G., 2001:
SNPs in the apo unique kringles-population spectra and effect on the Lp plasma levels

Bessudo, A.; Yakir, A.; Tchelet, A.; Cohen, D.; Navot, N., 2001:
SNPs in the holyland The Israeli scene

Wang, X.; Meng, X.; Song, B.; Qiu, X.; Liu, H., 2010:
SNPs in the myostatin gene of the mollusk Chlamys farreri: association with growth traits

Beilby, J.P.; Burley, J.; Chapman, C.M.L.; Mcquillan, B.M.; Hunt, C.; Hung, J.; Thompson, P.L., 2001:
SNPs in the scavenger receptor class B type 1 and cholesterol ester transfer protein gene and the risk of atherosclerosis

Hirowatari, K.; Tanikawa, Y.; Mohri, H.; Watanabe, K., 2000:
SNPs of mitochondrial ND5 gene, found in and among the meta-populations of papilionid butterfly, Luehdorfia japonica

Nelson, David, L., 2001:
SNPs, linkage disequilibrium, human genetic variation and Native American culture

Donnelly, P.J.; Wiuf, C., 1999:
SNPs, linkage disequilibrium, shared chromosomal segments, and genome-wide association mapping

Kunkel, M.A.; Liberchuk, R.; Gelfand, C.A.; Boyce Jacino, M., 2001:
SNPstream 5K, a microsphere-based system for determination of single nucleotide polymorphisms by primer extension

Hama, J.; Goldfarb, M.; Weinstein, D.C., 2001:
SNT-1 is a component of the FGF pathway that functions during Xenopus development

Higgins, K.J.; Saville, B.; Safe, S., 2003:
SNURF and MMS19 as coactivators of estrogen receptor alpha-mediated gene expression in breast cancer cells

Lee, L.L.; Muizelaar, J.P.; Lyeth, B.G.; Berman, R.F., 2000:
SNX-185, an N-type calcium channel blocker, is neuroprotective in a rat LFP brain injury model

Newcomb, R.; Chen, X.H.a; Dean, R.; Dayanithi, G.; Cong, R.; Szoke, B.; Lemos, J.; Bowersox, S.; Miljanich, G., 2000:
SNX-482 A novel class E calcium channel antagonist from tarantula venom

O'Brien, J.C., 2001:
SNIPpets from the Third International Meeting on Single Nucleotide Polymorphism and Complex Genome Analysis, September 8-11, 2000, Taos, New Mexico, USA

Wehner, F.; Tinel, H.; Kinne, R.K.H., 1999:
SO4-/OH- exchange mediated uptake of bromo-sulphthalein leads to an increase of rat hepatocyte K+ conductance

Ogle, S.M.; Breidt, F.J.y; Eve, M.D.; Paustian, K., 2002:
SOC sequestration in US agricultural lands between 1992 and 1997 Uncertainty analysis

Yahata, Y.; Yamasaki, K.; Shirakata, Y.; Tohyama, M.; Sayama, K.; Hashimoto, K., 2004:
SOCS I is a negative regulator of the MyD88-independent signaling pathway of the LPS-induced TLR4 natural immune response in HDMEC

Mahdi, R.M.; Li, W.; Chepelinsky, A.B.; Egwuagu, C.E., 2000:
SOCS genes are constitutively and differentially expressed in rodent lenses

Turnley, A.M.; Bartlett, P.F., 2000:
SOCS genes in the nervous system role in cell fate determination and neural cell function

Auernhammer, C.J.; Bousquet, C.; Chesnokova, V.; Melmed, S., 2000:
SOCS proteins Modulators of neuroimmunoendocrine function Impact on corticotroph LIF signaling

Chen, X.P.; Losman, J.A.; Rothman, P., 2000:
SOCS proteins, regulators of intracellular signaling

Fujimoto, M.; Tsutsui, H.; Xingshou, O.; Tokumoto, M.; Watanabe, D.; Shima, Y.; Hirakata, H.; Kawase, I.; Nakanishi, K.; Kishimoto, T.; Naka, T., 2002:
SOCS-1 as an inhibitor of systemic autoimmunity

Kimura, A.; Nakagawa, R.; Fujimoto, M.; Abe, T.; Xingshou, O.; Watanabe, D.; Taga, T.; Kishimoto, T.; Naka, T., 2002:
SOCS-1 inhibits TNF-a-induced cell death through regulation of JAK

Watanabe, D.; Ezoe, S.; Saito, Y.; Kimura, A.; Fujimoto, M.; Tachibana, I.; Matsumura, I.; Tanaka, T.; Kanakura, Y.; Kawase, I.; Kishimoto, T.; Naka, T., 2003:
SOCS-1 is silenced in hematopoietic malignancies

Fruchtman, S.; Simmons, J.G.; Wilkins, H.R.; Sartor, R.B.lfour; Greenhalgh, C.J.; Heath, J.K.; Lund, P.K.y, 2002:
SOCS-2 deficiency leads to increased intestinal collagen deposition and STAT3 activation in a mouse model of mucosal injury, inflammation and repair

Greenhalgh, C.J.; Thaus, A.L.; Fabri, L.; Morgan, P.O.; Baca, M.; Nicola, N.A.; Alexander, W.S.; Hilton, D.J., 2004:
SOCS-2 is a regulator of growth hormone signalling

Mahadevan, D.; Baker, A.F.; Tate, W.; Vankayalapati, H.; Glinsmann Gibson, B.J.; Georgiev, I.; Saldanha, J.; List, A.F., 2003:
SOCS-3 targets the SH3 domains of PI-3K and Grb2 through its polyproline-rich linker between the SH2 and SOCS box domains

Yamasaki, K.; Hanakawa, Y.; Tokumaru, S.; Toriu, N.; Shirakata, Y.; Hashimoto, K., 2000:
SOCS/CIS regulates cytokine signal pathway in normal human keratinocytes

Chim, C.S.; Kwong, Y.L.; Fung, T.K.; Liang, R., 2003:
SOCS1 and SHP1 hypermethylation in multiple myeloma Potential implications for epigenetic activation of the Jak/STAT pathway

Takahashi, N.; Saito, Y.; Kuwahara, K.; Harada, M.; Kawakami, R.; Nakagawa, Y.; Nakanishi, M.; Tanimoto, K.; Yasuno, S.; Usami, S.; Saito, Y.; Nakao, K., 2002:
SOCS1 and SOCS3 inhibit hypertrophic responses to cardiotrophin-1 through inhibition of MEK5-ERK5 pathway independent of STAT3 suppression in neonatal rat ventricular myocytes

Yamasaki, K.; Hanakawa, Y.; Tokumaru, S.; Toriu, N.; Tohyama, M.; Shirakata, Y.; Sayama, K.; Hashimoto, K., 2000:
SOCS1/JAB and SOCS3/CIS3 are major negative regulators in the STAT-signaling pathway of normal human keratinocytes

Tannahill, G.M.; Hibbert, L.; Johnston, J.A., 2003:
SOCS2 an inhibitor or not?

Yoshimura, A.; Mori, H.; Hanada, T., 2003:
SOCS3 A central regulator of IL-6/gp130 signaling and inflammation

Calderon Rodriguez, S.; Umana Perez, A.; Sanchez Gomez, M., 2004:
SOCS3 and SOCS2 are important regulators of muscle tissue sensitivity to GH in protein restricted rats

Mccann, N.M.; Ferguson, P.; Mcvicar, D.; Johnston, J.A., 2003:
SOCS3 binds to immune inhibitory receptors

Blythe, S.; Symes, A.J., 2001:
SOCS3 negatively regulates gp130 cytokine signal transduction through tyrosine 759 of the gp130 receptor

Lord, K.A.; King, A.G.; Levin, R.A.; Dillon, S.B., 2000:
SOCS3 plays an important negative regulatory role in myeloid colony formation

Woods, K.S.; Mcnay, D.; Turton, J.P.G.; Dattani, M.T., 2001:
SOD A multigenic disorder?

Bigot, Aélie.; Vasseur, P.; Rodius, Fçois., 2010:
SOD and CAT cDNA cloning, and expression pattern of detoxification genes in the freshwater bivalve Unio tumidus transplanted into the Moselle river

Molinari, S., 2003:
SOD as a tool of molecular diagnostics of plant parasitic nematodes

Onuma, S.; Nakanishi, K.; Kuboki, K.; Inokuchi, T., 2003:
SOD mimetic tempol decreases blood pressure while increasing renal medullary blood flow in hyperinsulinemic-hypertensive rats

Andringa, K.K.; Weydert, C.J.; Walsh, S.A.; Peters, S.S.; Oberley, L.W.; Salvemini, D.; Riley, D.P.; Spitz, D.R., 2002:
SOD mimics as adjuvants to chemotherapy protocols involving Adriamycin

Jovic, M.; Nedovic, Z.; Lalic, J.; Cosic, V.; Ristic, T.; Ljubenovic, M., 2001:
SOD, vitamin C and vitamin E in workers with parathion

Woodman, C.R.; Rush, J.W.E.; Parker, J.L.; Price, E.M.; Laughlin, M.H., 2000:
SOD-1 mRNA expression in porcine coronary arterioles Influence of coronary occlusion

Bidmon, H.; Koehling, R.; Paulus, W.; Panneck, H.; Lahl, R.; Kato, K.; Speckmann, E.; Zilles, K., 2001:
SOD-2 and COX-2 in dysplastic cells observed in epileptic foci of human brains

Alhadlaq, H.; Khramtsov, V.; Berliner, L.; Zuo, L.; Clanton, T., 1999:
SOD-like behavior of DEPMPO Implications for 31P-NMR spin trapping

Beaujeux, T.P.; Schofield, E.L.; Shaw, P.J.; Wood, J.D., 2002:
SOD1 aggregation in familial amyotrophic lateral sclerosis

Huang, C.Y.; Kim, G.W.; Chan, P.H., 2001:
SOD1 down-regulates AP-1 and NF-KB expression after photothrombotic ischemia in mice

Gellera, C.; Testa, D.; Passariello, P.; Mineri, R.; Morandi, L.; Sabatelli, M.; Munerati, E.; Corbo, M.; Mariotti, C.; Silani, V.; D.D.nato, S.; Taroni, F., 2003:
SOD1 gene mutations in amyotrophic lateral sclerosis Italian patients

Brannstrom, T.; Emhill, K.; Jonsson, A.; Nilson, P.; Andersen, P.; Forsgren, L.; Marklund, S., 1999:
SOD1 immunoreactive precipitates in mice transgenic for human SOD1 with and without mutations

Mariotti, R.; Bressan, C.; Cristino, L.; Boscolo, S.; Bentivoglio, M., 2001:
SOD1 mutation interferes with the motoneuron response to peripheral damage

Shadrina, M.I.; Levitsky, G.N.; Kondratyeva, Y.A.; Slominsky, P.A.; Skvortsova, V.I.; Limborska, S.A., 1999:
SOD1 mutation screening in sporadic ALS patients from Russia

Morita Fujimura, Y.; Fujimura, M.; Sugawara, T.; Copin, J.C.; Epstein, C.J.; Chan, P.H., 1999:
SOD1 prevents the early release of mitochondrial cytochrome C and subsequent apoptosis after focal cerebral ischemia in mice

Patel, M.N.; Day, B.J.; Wallace, D.C.; Liang, L.P.ng, 2001:
SOD2-deficient mice exhibit spontaneous age-related seizures and increased susceptibility to kainate-induced oxidative damage and apoptosis

Malaty, H.M.; Wilsey, M.J.; Abudayyeh, S.; Graham, D.Y.; Wristers, K.; Rabeneck, L.R., 2002:
SODA in children A new outcome measure in relation to Helicobacter pylori infection in children with recurrent abdominal pain

Rabeneck, L.; Wristers, K.; Ambriz, E., 2001:
SODA on the web A novel method for collecting information on patient outcomes in dyspepsia

Powers, S.; Zeng, R.W.ndy, 2002:
SODD gene expression in cancer

Goeddel, D.V.; Jiang, Y., 2000:
SODD-specific antibodies and methods

Fernández, J.; González-Martínez, S.C., 2010:
sofsog: a suite of programs to avoid inbreeding in plantation designs

Zheng, Y.; Mellem, J.E.; Maricq, A.V., 2001 :
SOL-1 encodes a novel protein that is required for GLR-1 glutamate receptor function in C elegans

Horvatin, P.J.; Bertram, P.E., 2001:
SOLEC Its more than a conference

Patel, N.B.; Diop, A.G.; Daniels, W.; Zigmond, M.J.; Kalaria, R.N., 1999:
SONA and the promotion of research and teaching of neuroscience in Africa

Fervers, B.; Hardy, J.; Blanc-Vincent, M.P.; Theobald, S.; Bataillard, A.; Farsi, F.; Gory, G.; Debuiche, S.; Guillo, S.; Renaud-Salis, J.L.; Pinkerton, R.; Bey, P.; Philip, T., 2001:
SOR: project methodology

Durand-Zaleski, I.; Philip, T., 2001:
SOR Project: the French context

Qannari,E.M.; Cariou,V.; Teillet,E.; Schlich,P., 2010:
SORT-CC a procedure for the statistical treatment of free sorting data

Sun, Q.; Petrosino, J.F.; Rosenberg, S.M.; Margolin, W., 2002:
SOS induction and requirement of functional RecA in mukB null mutants of E coli

Dobnig, H.; Piswanger Soelkner, C.; Friedl, G.; Berghold, A.; Scheruebel, C.; Fahrleitner, A.; Obermayer Pietsch, B.; Leb, G., 1999:
SOS-HIP study Design of a 3-year hip-fracture prevention trial in institutionalized high-risk patients using ibandronate, calcium and vitamin D

Sato, Machikatsu, 1999:
Sosa

Sutherland, M.S.K.ng; Geoghegan, J.; Winkler, D.G.; Hayes, T.; Ursino, R.J.; Staehling Hampton, K.; Zhao, L.; Latham, J.A., 2001:
SOST, a BMP antagonist expressed in mature osteoblasts, regulates bone formation

Koopman, P.; Pennisi, D.; James, K.; Hosking, B.; Muscat, G.E.O.; Olsson, J., 2000:
SOX genes in development and disease

Dorkins, H.; Pingault, V.; Grant, H.; Goosens, M.; Chapman, C., 2000:
SOX10 gene deletion in a family with Waardenburg-Shah syndrome

Bondurand, N.; Kuhlbrodt, K.; Pingault, V.; Enderich, J.; Sajus, M.; Hennekam, R.C.M.; Read, A.P.; Wegner, M.; Goossens, M., 1999:
SOX10 mutation in a mild form of the Yemenite deaf-blind hypopigmentation syndrome

Park, Y.; Park, H.; Yoo, E.; Kim, D., 2003:
SOX13 autoantibodies are likely to be a supplementary marker for type 1 diabetes in Korea

Wilmore, H.P.; Smith, M.J.; Wilcox, S.; Bell, K.M.; Sinclair, A.H., 1999:
SOX14 maps to human chromosome 3q22-23 and is expressed in the central nervous system and apical ectodermal ridge of the developing chick limb

Uchikawa, M.; Matsumata, M.; Kamachi, Y.; Kondoh, H., 2001:
SOX2 regulates N-cadherin expression in development of the cranial placodes